|
|
☒
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
||
|
For the Fiscal Year Ended
|
December 31, 2019
|
|
|
|
Delaware
|
|
76-0346924
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification No.)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Stock, $0.01 par value
|
WLK
|
The New York Stock Exchange
|
1.625% Senior Notes due 2029
|
WLK29
|
The New York Stock Exchange
|
Large accelerated filer
|
|
☒
|
|
Accelerated filer
|
|
☐
|
Non-accelerated filer
|
|
☐
|
|
Smaller reporting company
|
|
☐
|
|
|
|
|
Emerging growth company
|
|
☐
|
•
|
future operating rates, margins, cash flows and demand for our products;
|
•
|
industry market outlook, including the price of crude oil;
|
•
|
production capacities;
|
•
|
currency devaluation;
|
•
|
our ability to borrow additional funds under our credit agreement;
|
•
|
our ability to meet our liquidity needs;
|
•
|
our ability to meet debt obligations under our debt instruments;
|
•
|
our intended quarterly dividends;
|
•
|
future capacity additions and expansions in the industries in which we compete;
|
•
|
results of acquisitions;
|
•
|
timing, funding and results of capital projects;
|
•
|
pension plan obligations, funding requirements and investment policies;
|
•
|
compliance with present and future environmental regulations and costs associated with environmentally-related penalties, capital expenditures, remedial actions and proceedings, including any new laws, regulations or treaties that may come into force to limit or control carbon dioxide and other GHG emissions or to address other issues of climate change;
|
•
|
effects of pending legal proceedings; and
|
•
|
timing of and amount of capital expenditures.
|
•
|
general economic and business conditions;
|
•
|
the cyclical nature of the chemical and building products industries;
|
•
|
the availability, cost and volatility of raw materials and energy;
|
•
|
uncertainties associated with the United States, European and worldwide economies, including those due to political tensions and unrest in the Middle East and elsewhere;
|
•
|
current and potential governmental regulatory actions in the United States and other countries;
|
•
|
industry production capacity and operating rates;
|
•
|
the supply/demand balance for our products;
|
•
|
competitive products and pricing pressures;
|
•
|
instability in the credit and financial markets;
|
•
|
access to capital markets;
|
•
|
terrorist acts;
|
•
|
operating interruptions (including leaks, explosions, fires, weather-related incidents, mechanical failure, unscheduled downtime, labor difficulties, transportation interruptions, spills and releases and other environmental risks);
|
•
|
changes in laws or regulations, including trade policies;
|
•
|
technological developments;
|
•
|
foreign currency exchange risks;
|
•
|
our ability to implement our business strategies; and
|
•
|
creditworthiness of our customers.
|
Product
|
|
Annual Capacity
|
|
End Uses
|
|
Principal Manufacturing Facilities (2) (3)
|
|
|
|
(Millions of pounds)
|
|
|
|
|
|
Ethylene (1)
|
|
2,990
|
|
|
Polyethylene, ethylene dichloride ("EDC"), styrene, ethylene oxide/ethylene glycol
|
|
Lake Charles, Louisiana
|
Low-Density Polyethylene ("LDPE")
|
|
1,500
|
|
|
High clarity packaging and bags, shrink films, food packaging, coated paper board, cup stock, paper folding cartons, lids, closures and general purpose molding
|
|
Lake Charles, Louisiana
Longview, Texas
|
Linear Low-Density Polyethylene ("LLDPE")
|
|
1,070
|
|
|
Heavy-duty films and bags, general purpose liners
|
|
Lake Charles, Louisiana
Longview, Texas
|
Styrene
|
|
570
|
|
|
Consumer disposables, packaging material, appliances, paints and coatings, resins and building materials
|
|
Lake Charles, Louisiana
|
(1)
|
Production capacity owned by OpCo.
|
(2)
|
We lease the land on which our Longview, Texas facility is located.
|
(3)
|
We own the Lake Charles, Louisiana facility.
|
Product (1)
|
|
Annual Capacity (2)
|
|
End Uses
|
|
Principal Manufacturing Facilities (4) (5) (6)
|
|
|
|
(Millions of pounds)
|
|
|
|
|
|
Specialty PVC
|
|
1,090
|
|
|
Automotive sealants, cable sheathing, medical applications and other applications
|
|
Burghausen, Gendorf, Schkopau and Cologne, Germany
|
Commodity PVC
|
|
6,700
|
|
|
Construction materials including pipe, siding, profiles for windows and doors, film and sheet for packaging and other applications
|
|
Calvert City, Kentucky,
Geismar, Louisiana,
Plaquemine, Louisiana,
Aberdeen, Mississippi,
Cologne and Knapsack, Germany
|
VCM
|
|
7,630
|
|
|
PVC, PVC Compounds
|
|
Calvert City, Kentucky,
Geismar, Louisiana,
Plaquemine, Louisiana,
Lake Charles, Louisiana,
Gendorf and Knapsack, Germany
|
Chlorine
|
|
7,140
|
|
|
VCM, organic/inorganic chemicals, bleach
|
|
Calvert City, Kentucky,
Geismar, Louisiana,
Plaquemine, Louisiana,
Lake Charles, Louisiana,
Natrium, West Virginia,
Gendorf and Knapsack, Germany
|
Caustic Soda
|
|
7,860
|
|
|
Pulp and paper, organic/inorganic chemicals, neutralization, alumina
|
|
Calvert City, Kentucky,
Geismar, Louisiana,
Plaquemine, Louisiana,
Lake Charles, Louisiana,
Natrium, West Virginia,
Gendorf and Knapsack, Germany
|
Chlorinated Derivative Products
|
|
2,290
|
|
|
Coatings, flavorants, films, refrigerants, water treatment applications, chemicals and pharmaceutical production
|
|
Lake Charles, Louisiana,
Natrium, West Virginia,
Plaquemine, Louisiana,
Longview, Washington,
Beauharnois, Canada
|
Ethylene (3)
|
|
1,760
|
|
|
VCM
|
|
Calvert City, Kentucky
|
Building Products and PVC Compounds
|
|
3,380
|
|
|
Pipe: water and sewer, plumbing, irrigation, conduit; fittings; profiles and foundation building products; exteriors; window and door components; deck components; siding, trim and mouldings; film and sheet; composite roof tiles; Compounds: automotive interior, automotive exterior, stabilizers, medical applications, profiles, moldings, electrical products, casing and packaging
|
|
|
(1)
|
EDC, a VCM intermediate product, is not included in the table.
|
(2)
|
Includes capacity related to our 95%- and 60%-owned Asian joint ventures.
|
(3)
|
Includes production capacity in Calvert City owned by OpCo and our portion of LACC's production capacity in Lake Charles.
|
(4)
|
Except as noted in notes (5) and (6) below, we own each of these facilities.
|
(5)
|
We lease the land on which our Gendorf, Burghausen, Knapsack, Schkopau and Cologne, Germany and Longview, Washington facilities are located.
|
(6)
|
We lease a portion of the land on which our Aberdeen and Calvert City facilities are located.
|
•
|
In May 2013, an amendment to an existing consent order agreed to by the West Virginia Department of Environmental Protection and a predecessor of Axiall required that it, among other things, pay a penalty in the amount of $449,000 and continue certain corrective actions associated with discharges of hexachlorocyclohexane (commonly referred to as BHC) from the Natrium facility's effluent discharge outfalls. The penalty was paid and corrective actions required are on-going per a December 2018 agreement to extend the compliance date under the amended consent order. The amended consent order also imposes stipulated penalties for exceedances of the facility's interim effluent discharge limits, which penalties we believe may, in the aggregate, reach or exceed $100,000.
|
•
|
During September 2010, our vinyls facilities in Lake Charles and Plaquemine each received a Consolidated Compliance Order and Notice of Potential Penalty, alleging violations of various requirements of those facilities' air permits, based largely on self-reported permit deviations related to record-keeping violations. In May 2018, we reached an agreement in principal with the Louisiana Department of Environmental Quality to resolve these consolidated enforcement matters for a penalty of $162,500. The settlement agreement is subject to public comment and approval by the Louisiana Attorney General.
|
•
|
For several years, the EPA has been conducting an enforcement initiative against petroleum refineries and petrochemical plants with respect to emissions from flares. On April 21, 2014, we received a Clean Air Act Section 114 Information Request from the EPA which sought information regarding flares at the Calvert City facility and certain Lake Charles facilities. The EPA has informed us that the information provided leads the EPA to believe that some of the flares are out of compliance with applicable standards. The EPA has indicated that it is seeking a consent decree that would obligate us to take corrective actions relating to the alleged noncompliance. We believe the resolution of these matters may require the payment of a monetary sanction in excess of $100,000.
|
•
|
Region Six of the EPA has investigated and inspected our compliance with Risk Management Program requirements under the Clean Air Act at our Geismar facility. In November 2019, we reached an agreement in principle with the EPA to resolve this matter by consent agreement and final order for a penalty in the amount of $132,000, in addition to a supplemental environmental project with a cost to us of $116,200.
|
•
|
On November 15, 2019, the EPA issued a notice of violation and opportunity to show cause letter alleging violations of certain requirements under the Toxic Substances Control Act identified during the agency's inspection of one of our Lake Charles facilities. We believe the resolution of this matter may require payment of a monetary sanction in excess of $100,000.
|
•
|
On November 24, 2014, we entered into an agreed order with the Kentucky Energy and Environmental Cabinet ("KEEC") regarding our Kentucky Pollutant Discharge Elimination System permit limits for hexachlorobenzene
|
Category
|
|
Number
|
|
Olefins segment
|
|
840
|
|
Vinyls segment
|
|
8,250
|
|
Corporate and other
|
|
340
|
|
•
|
general economic conditions, including in the United States, Europe and Asia;
|
•
|
new capacity additions in North America, Europe, Asia and the Middle East;
|
•
|
the level of business activity in the industries that use our products;
|
•
|
competitor action;
|
•
|
technological innovations;
|
•
|
currency fluctuations;
|
•
|
increases in interest rates;
|
•
|
international events and circumstances;
|
•
|
pandemics and other public health threats;
|
•
|
war, sabotage, terrorism and civil unrest;
|
•
|
governmental regulation, including in the United States, Europe and Asia;
|
•
|
public attitude towards climate change and safety, health and the environment;
|
•
|
perceptions of our products by potential buyers of our products, as well as the public generally, and related changes in behavior, including with respect to recycling;
|
•
|
severe weather and natural disasters; and
|
•
|
credit worthiness of customers and vendors.
|
•
|
product price;
|
•
|
balance of product supply/demand;
|
•
|
material, technology and process innovation;
|
•
|
technical support and customer service;
|
•
|
quality;
|
•
|
reliability of raw material and utility supply;
|
•
|
availability of potential substitute materials; and
|
•
|
product performance.
|
•
|
the emergence of new domestic and international competitors;
|
•
|
the rate of capacity additions by competitors;
|
•
|
changes in customer base due to mergers;
|
•
|
the intensification of price competition in our markets;
|
•
|
the introduction of new or substitute products by competitors; and
|
•
|
the technological innovations of competitors.
|
•
|
pipeline leaks and ruptures;
|
•
|
explosions;
|
•
|
fires;
|
•
|
severe weather and natural disasters;
|
•
|
mechanical failure;
|
•
|
unscheduled downtime;
|
•
|
labor difficulties;
|
•
|
transportation interruptions;
|
•
|
transportation accidents involving our products;
|
•
|
remediation complications;
|
•
|
chemical spills, discharges or releases of toxic or hazardous substances or gases;
|
•
|
other environmental risks;
|
•
|
sabotage;
|
•
|
terrorist attacks; and
|
•
|
political unrest.
|
•
|
unexpectedly long delivery times for, or shortages of, key equipment, parts or materials;
|
•
|
shortages of skilled labor and other personnel necessary to perform the work;
|
•
|
delays and performance issues;
|
•
|
failures or delays of third-party equipment vendors or service providers;
|
•
|
unforeseen increases in the cost of equipment, labor and raw materials;
|
•
|
work stoppages and other labor disputes;
|
•
|
unanticipated actual or purported change orders;
|
•
|
disputes with contractors and suppliers;
|
•
|
design and engineering problems;
|
•
|
latent damages or deterioration to equipment and machinery in excess of engineering estimates and assumptions;
|
•
|
financial or other difficulties of our contractors and suppliers;
|
•
|
sabotage;
|
•
|
terrorist attacks;
|
•
|
interference from adverse weather conditions; and
|
•
|
difficulties in obtaining necessary permits or in meeting permit conditions.
|
•
|
a portion of our cash flows from operations will be dedicated to the payment of interest and principal on our debt and will not be available for other purposes;
|
•
|
we may not be able to obtain necessary financing in the future for working capital, capital expenditures, acquisitions, debt service requirements or other purposes;
|
•
|
our less leveraged competitors could have a competitive advantage because they have greater flexibility to utilize their cash flows to improve their operations;
|
•
|
we may be exposed to risks inherent in interest rate fluctuations because some of our borrowings are at variable rates of interest, which would result in higher interest expense in the event of increases in interest rates;
|
•
|
we could be vulnerable in the event of a downturn in our business that would leave us less able to take advantage of significant business opportunities and to react to changes in our business and in market or industry conditions; and
|
•
|
should we pursue additional expansions of existing assets or acquisition of third party assets, we may not be able to obtain additional liquidity at cost effective interest rates.
|
•
|
pay dividends on, redeem or repurchase our capital stock;
|
•
|
make investments and other restricted payments;
|
•
|
incur additional indebtedness or issue preferred stock;
|
•
|
create liens;
|
•
|
permit dividend or other payment restrictions on our restricted subsidiaries;
|
•
|
sell all or substantially all of our assets or consolidate or merge with or into other companies;
|
•
|
engage in transactions with affiliates; and
|
•
|
engage in sale-leaseback transactions.
|
•
|
we may fail to integrate the businesses we acquire into a cohesive, efficient enterprise;
|
•
|
our resources, including management resources, are limited and may be strained if we engage in a large acquisition or significant number of acquisitions, and acquisitions may divert our management's attention from initiating or carrying out programs to save costs or enhance revenues; and
|
•
|
our failure to retain key employees and contracts of the businesses we acquire.
|
•
|
the composition of our Board of Directors and, through the Board, any determination with respect to our business direction and policies, including the appointment and removal of officers and the determination of compensation;
|
•
|
any determinations with respect to mergers or other business combinations or the acquisition or disposition of assets;
|
•
|
our financing decisions, capital raising activities and the payment of dividends; and
|
•
|
amendments to our amended and restated certificate of incorporation or amended and restated bylaws.
|
•
|
business opportunities that may be presented to the principal stockholder affiliates and to our officers and directors associated with the principal stockholder affiliates, and competition between the principal stockholder affiliates and us within the same lines of business;
|
•
|
the solicitation and hiring of employees from each other; and
|
•
|
agreements with the principal stockholder affiliates relating to corporate services that may be material to our business.
|
Period
|
|
Total Number
of Shares
Purchased (1)
|
|
Average Price
Paid Per
Share
|
|
Total Number
of Shares
Purchased as Part
of Publicly
Announced Plans
or Programs (2)
|
|
Maximum Number
(or Approximate
Dollar Value) of
Shares that
May Yet Be
Purchased Under the
Plans or Programs (2)
|
||||||
October 2019
|
|
60,758
|
|
|
$
|
60.30
|
|
|
—
|
|
|
$
|
184,872,000
|
|
November 2019
|
|
32
|
|
|
73.95
|
|
|
—
|
|
|
184,872,000
|
|
||
December 2019
|
|
10,537
|
|
|
67.01
|
|
|
—
|
|
|
184,872,000
|
|
||
Total
|
|
71,327
|
|
|
$
|
61.30
|
|
|
—
|
|
|
|
(1)
|
Includes 60,758, 32 and 10,537 shares withheld in October 2019, November 2019 and December 2019, respectively, in satisfaction of withholding taxes due upon the vesting of restricted stock units granted to our employees under the 2013 Plan.
|
(2)
|
In November 2014, our Board of Directors authorized a $250 million stock repurchase program (the "2014 Program"). In November 2015, our Board of Directors approved the expansion of the 2014 Program by an additional $150 million. In August 2018, our Board of Directors approved the further expansion of the existing 2014 Program by an additional $150 million. As of December 31, 2019, 6,080,191 shares of our common stock had been acquired at an aggregate purchase price of approximately $365 million under the 2014 Program. Transaction fees and commissions are not reported in the average price paid per share in the table above. Decisions regarding the amount and the timing of purchases under the 2014 Program will be influenced by our cash on hand, our cash flows from operations, general market conditions and other factors. The 2014 Program may be discontinued by our Board of Directors at any time.
|
Plan Category
|
|
Number of securities
to be issued upon
exercise of outstanding options,
warrants and rights
(a)
|
|
Weighted-average
exercise price of
outstanding
options, warrants
and rights
(b)
|
|
Number of securities
remaining available
for future issuance under equity
compensation plans
(excluding securities
reflected in column
(a))
(c)
|
||||
Equity compensation plans approved by security holders
|
|
1,926,448
|
|
(1)
|
$
|
60.29
|
|
(2)
|
4,009,687
|
|
Equity compensation plans not approved by security holders
|
|
N/A
|
|
|
N/A
|
|
|
N/A
|
|
|
Total
|
|
1,926,448
|
|
|
$
|
60.29
|
|
(2)
|
4,009,687
|
|
(1)
|
Includes shares reserved for issuance pursuant to restricted stock units, stock options and performance stock units.
|
(2)
|
Price applies only to the stock options included in column (a). Exercise price is not applicable to the other awards included in column (a).
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
2019
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
(dollars in millions, except share amounts, per share data and volume data)
|
||||||||||||||||||
Statement of Operations Data:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Net sales
|
|
$
|
8,118
|
|
|
$
|
8,635
|
|
|
$
|
8,041
|
|
|
$
|
5,076
|
|
|
$
|
4,463
|
|
Gross profit
|
|
1,260
|
|
|
1,987
|
|
|
1,761
|
|
|
983
|
|
|
1,190
|
|
|||||
Selling, general and administrative expenses
|
|
458
|
|
|
445
|
|
|
399
|
|
|
258
|
|
|
218
|
|
|||||
Amortization of intangibles
|
|
109
|
|
|
101
|
|
|
108
|
|
|
38
|
|
|
7
|
|
|||||
Restructuring, transaction and integration-related costs
|
|
37
|
|
|
33
|
|
|
29
|
|
|
104
|
|
|
—
|
|
|||||
Income from operations
|
|
656
|
|
|
1,408
|
|
|
1,225
|
|
|
583
|
|
|
965
|
|
|||||
Interest expense
|
|
(124
|
)
|
|
(126
|
)
|
|
(159
|
)
|
|
(79
|
)
|
|
(35
|
)
|
|||||
Other income, net
|
|
38
|
|
|
52
|
|
|
15
|
|
|
54
|
|
|
33
|
|
|||||
Income before income taxes
|
|
570
|
|
|
1,334
|
|
|
1,081
|
|
|
558
|
|
|
963
|
|
|||||
Provision for (benefit from) income taxes
|
|
108
|
|
|
300
|
|
|
(258
|
)
|
|
138
|
|
|
298
|
|
|||||
Net income
|
|
462
|
|
|
1,034
|
|
|
1,339
|
|
|
420
|
|
|
665
|
|
|||||
Net income attributable to noncontrolling interests
|
|
41
|
|
|
38
|
|
|
35
|
|
|
21
|
|
|
19
|
|
|||||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
421
|
|
|
$
|
996
|
|
|
$
|
1,304
|
|
|
$
|
399
|
|
|
$
|
646
|
|
Earnings Per Share Attributable to Westlake Chemical Corporation:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
|
$
|
3.26
|
|
|
$
|
7.66
|
|
|
$
|
10.05
|
|
|
$
|
3.07
|
|
|
$
|
4.88
|
|
Diluted
|
|
$
|
3.25
|
|
|
$
|
7.62
|
|
|
$
|
10.00
|
|
|
$
|
3.06
|
|
|
$
|
4.86
|
|
Weighted average shares outstanding
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
|
128,395,184
|
|
|
129,401,823
|
|
|
129,087,043
|
|
|
129,367,712
|
|
|
131,823,707
|
|
|||||
Diluted
|
|
128,757,293
|
|
|
129,985,753
|
|
|
129,540,013
|
|
|
129,974,822
|
|
|
132,301,812
|
|
|||||
Balance Sheet Data (end of period):
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents
|
|
$
|
728
|
|
|
$
|
753
|
|
|
$
|
1,531
|
|
|
$
|
459
|
|
|
$
|
663
|
|
Marketable securities
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
520
|
|
|||||
Working capital (2)
|
|
1,501
|
|
|
1,659
|
|
|
1,496
|
|
|
1,225
|
|
|
1,652
|
|
|||||
Total assets
|
|
13,261
|
|
|
11,602
|
|
|
12,076
|
|
|
10,890
|
|
|
5,569
|
|
|||||
Total long-term debt, net
|
|
3,445
|
|
|
2,668
|
|
|
3,127
|
|
|
3,679
|
|
|
758
|
|
|||||
Total Westlake Chemical Corporation stockholders' equity
|
|
5,860
|
|
|
5,590
|
|
|
4,874
|
|
|
3,524
|
|
|
3,266
|
|
|||||
Cash dividends declared per share
|
|
$
|
1.0250
|
|
|
$
|
0.9200
|
|
|
$
|
0.8012
|
|
|
$
|
0.7442
|
|
|
$
|
0.6393
|
|
Other Operating Data:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash flows from:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Operating activities
|
|
$
|
1,301
|
|
|
$
|
1,409
|
|
|
$
|
1,528
|
|
|
$
|
867
|
|
|
$
|
1,079
|
|
Investing activities
|
|
(1,954
|
)
|
|
(754
|
)
|
|
(652
|
)
|
|
(2,563
|
)
|
|
(1,006
|
)
|
|||||
Financing activities
|
|
630
|
|
|
(1,427
|
)
|
|
6
|
|
|
1,687
|
|
|
(287
|
)
|
|||||
Depreciation and amortization
|
|
713
|
|
|
641
|
|
|
601
|
|
|
378
|
|
|
246
|
|
|||||
Capital expenditures
|
|
787
|
|
|
702
|
|
|
577
|
|
|
629
|
|
|
491
|
|
|||||
EBITDA (3)
|
|
1,407
|
|
|
2,101
|
|
|
1,841
|
|
|
1,015
|
|
|
1,244
|
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
2019
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
External Sales Volume (millions of pounds):
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Olefins Segment
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Polyethylene
|
|
2,565
|
|
|
2,438
|
|
|
2,363
|
|
|
2,392
|
|
|
2,445
|
|
|||||
Styrene, feedstock and other
|
|
880
|
|
|
671
|
|
|
828
|
|
|
794
|
|
|
1,182
|
|
|||||
Vinyls Segment
|
|
|
|
|
|
|
|
|
|
|
||||||||||
PVC, caustic soda and other
|
|
16,712
|
|
|
16,629
|
|
|
15,997
|
|
|
8,118
|
|
|
5,026
|
|
|||||
Building products
|
|
1,178
|
|
|
1,180
|
|
|
1,193
|
|
|
770
|
|
|
629
|
|
(1)
|
The historical selected financial and operational data should be read together with Item 7, Management's Discussion and Analysis of Financial Condition and Results of Operations, and Item 8, Financial Statements and Supplementary Data included in this Form 10-K.
|
(2)
|
Working capital equals current assets less current liabilities.
|
(3)
|
EBITDA (a non-GAAP financial measure) is calculated as net income before interest expense, income taxes, depreciation and amortization. The body of accounting principles generally accepted in the United States is commonly referred to as "GAAP." For this purpose, a non-GAAP financial measure is generally defined by the Securities and Exchange Commission ("SEC") as one that purports to measure historical or future financial performance, financial position or cash flows that (1) excludes amounts, or is subject to adjustments that have the effect of excluding amounts, that are included in the most directly comparable measure calculated and presented in accordance with GAAP in the statement of income, balance sheet or statement of cash flows (or equivalent statements) of the registrant; or (2) includes amounts, or is subject to adjustments that have the effect of including amounts, that are excluded from the most directly comparable measure so calculated and presented. In this report, we disclose non-GAAP financial measures, primarily earnings before interest, taxes, depreciation and amortization ("EBITDA"). The non-GAAP financial measures described in this Form 10-K are not substitutes for the GAAP measures of earnings and cash flows. EBITDA is included in this Form 10-K because our management considers it an important supplemental measure of our performance and believes that it is frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry, some of which present EBITDA when reporting their results. We regularly evaluate our performance as compared to other companies in our industry that have different financing and capital structures and/or tax rates by using EBITDA. In addition, we utilize EBITDA in evaluating acquisition targets. Management also believes that EBITDA is a useful tool for measuring our ability to meet our future debt service, capital expenditures and working capital requirements, and EBITDA is commonly used by us and our investors to measure our ability to service indebtedness. EBITDA is not a substitute for the GAAP measures of net income, income from operations and net cash provided by operating activities and is not necessarily a measure of our ability to fund our cash needs. In addition, it should be noted that companies calculate EBITDA differently and, therefore, EBITDA as presented for us may not be comparable to EBITDA reported by other companies. EBITDA has material limitations as a performance measure because it excludes interest expense, depreciation and amortization and income taxes. The following table reconciles EBITDA to net income, income from operations and net cash provided by operating activities.
|
|
|
Year Ended December 31,
|
||||||||||||||||||
|
|
2019
|
|
2018
|
|
2017
|
|
2016
|
|
2015
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
(dollars in millions)
|
||||||||||||||||||
Net cash provided by operating activities
|
|
$
|
1,301
|
|
|
$
|
1,409
|
|
|
$
|
1,528
|
|
|
$
|
867
|
|
|
$
|
1,079
|
|
Changes in operating assets and liabilities and other
|
|
(785
|
)
|
|
(313
|
)
|
|
(723
|
)
|
|
(346
|
)
|
|
(374
|
)
|
|||||
Deferred income taxes
|
|
(54
|
)
|
|
(62
|
)
|
|
534
|
|
|
(101
|
)
|
|
(40
|
)
|
|||||
Net income
|
|
462
|
|
|
1,034
|
|
|
1,339
|
|
|
420
|
|
|
665
|
|
|||||
Less:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Other income, net
|
|
38
|
|
|
52
|
|
|
15
|
|
|
54
|
|
|
33
|
|
|||||
Interest expense
|
|
(124
|
)
|
|
(126
|
)
|
|
(159
|
)
|
|
(79
|
)
|
|
(35
|
)
|
|||||
(Provision for) benefit from income taxes
|
|
(108
|
)
|
|
(300
|
)
|
|
258
|
|
|
(138
|
)
|
|
(298
|
)
|
|||||
Income from operations
|
|
656
|
|
|
1,408
|
|
|
1,225
|
|
|
583
|
|
|
965
|
|
|||||
Add:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Depreciation and amortization
|
|
713
|
|
|
641
|
|
|
601
|
|
|
378
|
|
|
246
|
|
|||||
Other income, net
|
|
38
|
|
|
52
|
|
|
15
|
|
|
54
|
|
|
33
|
|
|||||
EBITDA
|
|
$
|
1,407
|
|
|
$
|
2,101
|
|
|
$
|
1,841
|
|
|
$
|
1,015
|
|
|
$
|
1,244
|
|
•
|
the availability of feedstock from shale gas and oil drilling;
|
•
|
supply and demand for crude oil;
|
•
|
shortages of raw materials due to increasing demand;
|
•
|
ethane and liquefied natural gas exports;
|
•
|
capacity constraints due to higher construction costs for investments, construction delays, strike action or involuntary shutdowns;
|
•
|
the general level of business and economic activity; and
|
•
|
the direct or indirect effect of governmental regulation.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||
|
|
|
|
|
|
|
||||||
|
|
(dollars in millions, except per share data)
|
||||||||||
Net external sales
|
|
|
|
|
|
|
||||||
Olefins
|
|
|
|
|
|
|
||||||
Polyethylene
|
|
$
|
1,301
|
|
|
$
|
1,519
|
|
|
$
|
1,518
|
|
Styrene, feedstock and other
|
|
481
|
|
|
500
|
|
|
533
|
|
|||
Total Olefins
|
|
1,782
|
|
|
2,019
|
|
|
2,051
|
|
|||
Vinyls
|
|
|
|
|
|
|
||||||
PVC, caustic soda and other
|
|
5,068
|
|
|
5,359
|
|
|
4,769
|
|
|||
Building products
|
|
1,268
|
|
|
1,257
|
|
|
1,221
|
|
|||
Total Vinyls
|
|
6,336
|
|
|
6,616
|
|
|
5,990
|
|
|||
Total
|
|
$
|
8,118
|
|
|
$
|
8,635
|
|
|
$
|
8,041
|
|
|
|
|
|
|
|
|
||||||
Income (loss) from operations
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
260
|
|
|
$
|
573
|
|
|
$
|
655
|
|
Vinyls
|
|
451
|
|
|
913
|
|
|
639
|
|
|||
Corporate and other
|
|
(55
|
)
|
|
(78
|
)
|
|
(69
|
)
|
|||
Total income from operations
|
|
656
|
|
|
1,408
|
|
|
1,225
|
|
|||
Interest expense
|
|
(124
|
)
|
|
(126
|
)
|
|
(159
|
)
|
|||
Other income, net
|
|
38
|
|
|
52
|
|
|
15
|
|
|||
Provision for (benefit from) income taxes
|
|
108
|
|
|
300
|
|
|
(258
|
)
|
|||
Net income
|
|
462
|
|
|
1,034
|
|
|
1,339
|
|
|||
Net income attributable to noncontrolling interests
|
|
41
|
|
|
38
|
|
|
35
|
|
|||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
421
|
|
|
$
|
996
|
|
|
$
|
1,304
|
|
Diluted earnings per share
|
|
$
|
3.25
|
|
|
$
|
7.62
|
|
|
$
|
10.00
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2019
|
|
2018
|
||||||||
|
|
Average Sales
Price |
|
Volume
|
|
Average Sales
Price |
|
Volume
|
||||
Product sales price and volume percentage change from prior year
|
|
|
|
|
|
|
|
|
||||
Olefins
|
|
-21
|
%
|
|
+9
|
%
|
|
-1
|
%
|
|
—
|
%
|
Vinyls
|
|
-8
|
%
|
|
+3
|
%
|
|
+7
|
%
|
|
+4
|
%
|
Company average
|
|
-11
|
%
|
|
+5
|
%
|
|
+5
|
%
|
|
+3
|
%
|
(1)
|
Industry pricing data was obtained through IHS Markit ("IHS"). We have not independently verified the data.
|
(2)
|
Average Mont Belvieu spot prices of purity ethane over the period.
|
(3)
|
Average Mont Belvieu spot prices of non-TET propane over the period.
|
(4)
|
Average North American spot prices of ethylene over the period.
|
(5)
|
Average North American Net Transaction prices of polyethylene low density GP-Film grade over the period.
|
(6)
|
Average North American contract prices of styrene over the period.
|
(7)
|
Average USGC-CSLi index values for caustic soda over the period. As stated by IHS, "the caustic soda price listing represents the USGC-CSLi values. USGC-CSLi does not reflect contract price discounts, implementation lags, caps or other adjustments factors. Additionally, it is not intended to represent a simple arithmetic average of all market transactions occurring during the month. Rather, the USGC-CSLi is most representative of the month-to-month caustic soda price movement for contract volumes of liquid 50% caustic soda rather than the absolute value of contract prices at a particular point in time. It is intended to serve only as a benchmark."
|
(8)
|
Average North American contract prices of chlorine over the period. Effective January 1, 2019, IHS made a non-market average downward adjustment of $172.50 per short ton to chlorine prices. For comparability, we adjusted the prior period's chlorine price downward by $172.50 per short ton consistent with the IHS non-market adjustment.
|
(9)
|
Average North American contract prices of pipe grade PVC over the period. As stated by IHS, "the contract resin prices posted reflect an "index" or "market" for prices before discounts, rebates, incentives, etc."
|
(10)
|
Average North American export price for low density polyethylene GP-Film grade over the period.
|
(11)
|
Average North American low spot export prices of caustic soda over the period.
|
(12)
|
Average North American spot export prices of PVC over the period.
|
|
|
Payment Due by Period
|
||||||||||||||||||
|
|
Total
|
|
2020
|
|
2021-2022
|
|
2023-2024
|
|
Thereafter
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
(dollars in millions)
|
||||||||||||||||||
Contractual Obligations
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Long-term debt
|
|
$
|
3,500
|
|
|
$
|
—
|
|
|
$
|
250
|
|
|
$
|
—
|
|
|
$
|
3,250
|
|
Operating leases
|
|
545
|
|
|
106
|
|
|
152
|
|
|
98
|
|
|
189
|
|
|||||
Finance leases
|
|
16
|
|
|
3
|
|
|
5
|
|
|
5
|
|
|
3
|
|
|||||
Pension benefits funding
|
|
177
|
|
|
6
|
|
|
28
|
|
|
55
|
|
|
88
|
|
|||||
Post-retirement healthcare benefits
|
|
93
|
|
|
8
|
|
|
16
|
|
|
15
|
|
|
54
|
|
|||||
Purchase obligations
|
|
7,180
|
|
|
1,588
|
|
|
1,986
|
|
|
1,463
|
|
|
2,143
|
|
|||||
Interest payments
|
|
2,198
|
|
|
131
|
|
|
258
|
|
|
244
|
|
|
1,565
|
|
|||||
Asset retirement obligations
|
|
42
|
|
|
7
|
|
|
1
|
|
|
3
|
|
|
31
|
|
|||||
Total
|
|
$
|
13,751
|
|
|
$
|
1,849
|
|
|
$
|
2,696
|
|
|
$
|
1,883
|
|
|
$
|
7,323
|
|
Other Commercial Commitments
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Standby letters of credit
|
|
$
|
29
|
|
|
$
|
23
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
6
|
|
|
|
2019
|
||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||
|
|
|
|
|
||||
|
|
(dollars in millions)
|
||||||
Projected benefit obligation, end of year
|
|
$
|
703
|
|
|
$
|
144
|
|
Discount rate increases by 100 basis points
|
|
(75
|
)
|
|
(21
|
)
|
||
Discount rate decreases by 100 basis points
|
|
93
|
|
|
26
|
|
|
Page
|
|
|
Management's Report on Internal Control over Financial Reporting
|
|
Report of Independent Registered Public Accounting Firm
|
|
Consolidated Financial Statements:
|
|
Consolidated Balance Sheets as of December 31, 2019 and 2018
|
|
Consolidated Statements of Operations for the Years Ended December 31, 2019, 2018 and 2017
|
|
Consolidated Statements of Comprehensive Income for the Years Ended
December 31, 2019, 2018 and 2017
|
|
Consolidated Statements of Changes in Stockholders' Equity for the Years Ended
December 31, 2019, 2018 and 2017
|
|
Consolidated Statements of Cash Flows for the Years Ended December 31, 2019, 2018 and 2017
|
|
Notes to Consolidated Financial Statements
|
|
|
December 31,
|
||||||
|
|
2019
|
|
2018
|
||||
|
|
|
|
|
||||
|
|
(in millions of dollars, except
par values and share amounts)
|
||||||
ASSETS
|
|
|
|
|
||||
Current assets
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
728
|
|
|
$
|
753
|
|
Accounts receivable, net
|
|
1,036
|
|
|
1,037
|
|
||
Inventories
|
|
936
|
|
|
1,014
|
|
||
Prepaid expenses and other current assets
|
|
42
|
|
|
38
|
|
||
Total current assets
|
|
2,742
|
|
|
2,842
|
|
||
Property, plant and equipment, net
|
|
6,912
|
|
|
6,595
|
|
||
Operating lease right-of-use assets
|
|
443
|
|
|
—
|
|
||
Goodwill
|
|
1,074
|
|
|
1,002
|
|
||
Customer relationships, net
|
|
523
|
|
|
525
|
|
||
Other intangible assets, net
|
|
187
|
|
|
134
|
|
||
Equity method investments
|
|
1,112
|
|
|
253
|
|
||
Other assets, net
|
|
268
|
|
|
251
|
|
||
Total assets
|
|
$
|
13,261
|
|
|
$
|
11,602
|
|
LIABILITIES AND EQUITY
|
|
|
|
|
||||
Current liabilities
|
|
|
|
|
||||
Accounts payable
|
|
$
|
473
|
|
|
$
|
507
|
|
Accrued and other liabilities
|
|
768
|
|
|
676
|
|
||
Total current liabilities
|
|
1,241
|
|
|
1,183
|
|
||
Long-term debt, net
|
|
3,445
|
|
|
2,668
|
|
||
Deferred income taxes
|
|
1,255
|
|
|
1,159
|
|
||
Pension and other post-retirement benefits
|
|
360
|
|
|
337
|
|
||
Operating lease liabilities
|
|
355
|
|
|
—
|
|
||
Other liabilities
|
|
202
|
|
|
179
|
|
||
Total liabilities
|
|
6,858
|
|
|
5,526
|
|
||
Commitments and contingencies (Note 22)
|
|
|
|
|
|
|
||
Stockholders' equity
|
|
|
|
|
||||
Preferred stock, $0.01 par value, 50,000,000 shares authorized; no shares
issued and outstanding
|
|
—
|
|
|
—
|
|
||
Common stock, $0.01 par value, 300,000,000 shares authorized; 134,651,380 and
134,651,380 shares issued at December 31, 2019 and 2018, respectively
|
|
1
|
|
|
1
|
|
||
Common stock, held in treasury, at cost; 6,266,609 and 6,183,125 shares
at December 31, 2019 and 2018, respectively
|
|
(377
|
)
|
|
(382
|
)
|
||
Additional paid-in capital
|
|
553
|
|
|
556
|
|
||
Retained earnings
|
|
5,757
|
|
|
5,477
|
|
||
Accumulated other comprehensive loss
|
|
(74
|
)
|
|
(62
|
)
|
||
Total Westlake Chemical Corporation stockholders' equity
|
|
5,860
|
|
|
5,590
|
|
||
Noncontrolling interests
|
|
543
|
|
|
486
|
|
||
Total equity
|
|
6,403
|
|
|
6,076
|
|
||
Total liabilities and equity
|
|
$
|
13,261
|
|
|
$
|
11,602
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||
|
|
|
|
|
|
|
||||||
|
|
(in millions of dollars,
except share amounts and per share data)
|
||||||||||
Net sales
|
|
$
|
8,118
|
|
|
$
|
8,635
|
|
|
$
|
8,041
|
|
Cost of sales
|
|
6,858
|
|
|
6,648
|
|
|
6,280
|
|
|||
Gross profit
|
|
1,260
|
|
|
1,987
|
|
|
1,761
|
|
|||
Selling, general and administrative expenses
|
|
458
|
|
|
445
|
|
|
399
|
|
|||
Amortization of intangibles
|
|
109
|
|
|
101
|
|
|
108
|
|
|||
Restructuring, transaction and integration-related costs
|
|
37
|
|
|
33
|
|
|
29
|
|
|||
Income from operations
|
|
656
|
|
|
1,408
|
|
|
1,225
|
|
|||
Other income (expense)
|
|
|
|
|
|
|
||||||
Interest expense
|
|
(124
|
)
|
|
(126
|
)
|
|
(159
|
)
|
|||
Other income, net
|
|
38
|
|
|
52
|
|
|
15
|
|
|||
Income before income taxes
|
|
570
|
|
|
1,334
|
|
|
1,081
|
|
|||
Provision for (benefit from) income taxes
|
|
108
|
|
|
300
|
|
|
(258
|
)
|
|||
Net income
|
|
462
|
|
|
1,034
|
|
|
1,339
|
|
|||
Net income attributable to noncontrolling interests
|
|
41
|
|
|
38
|
|
|
35
|
|
|||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
421
|
|
|
$
|
996
|
|
|
$
|
1,304
|
|
Earnings per common share attributable to Westlake Chemical Corporation:
|
|
|
|
|
|
|
||||||
Basic
|
|
$
|
3.26
|
|
|
$
|
7.66
|
|
|
$
|
10.05
|
|
Diluted
|
|
$
|
3.25
|
|
|
$
|
7.62
|
|
|
$
|
10.00
|
|
Weighted average common shares outstanding
|
|
|
|
|
|
|
||||||
Basic
|
|
128,395,184
|
|
|
129,401,823
|
|
|
129,087,043
|
|
|||
Diluted
|
|
128,757,293
|
|
|
129,985,753
|
|
|
129,540,013
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||
|
|
|
|
|
|
|
||||||
|
|
(in millions of dollars)
|
||||||||||
Net income
|
|
$
|
462
|
|
|
$
|
1,034
|
|
|
$
|
1,339
|
|
Other comprehensive income (loss), net of income taxes
|
|
|
|
|
|
|
||||||
Pension and other post-retirement benefits
|
|
|
|
|
|
|
||||||
Pension and other post-retirement benefits reserves adjustment
|
|
(32
|
)
|
|
(33
|
)
|
|
19
|
|
|||
Amortization of benefits liability
|
|
—
|
|
|
—
|
|
|
2
|
|
|||
Income tax benefit (provision) on pension and other post-retirement benefits
|
|
8
|
|
|
8
|
|
|
(7
|
)
|
|||
Foreign currency translation adjustments
|
|
|
|
|
|
|
||||||
Foreign currency translation
|
|
17
|
|
|
(59
|
)
|
|
124
|
|
|||
Income tax provision on foreign currency translation
|
|
(4
|
)
|
|
—
|
|
|
(5
|
)
|
|||
Other comprehensive income (loss), net of income taxes
|
|
(11
|
)
|
|
(84
|
)
|
|
133
|
|
|||
Comprehensive income
|
|
451
|
|
|
950
|
|
|
1,472
|
|
|||
Comprehensive income attributable to noncontrolling interests,
net of tax of $2, $4 and $1 for 2019, 2018 and 2017, respectively
|
|
42
|
|
|
36
|
|
|
40
|
|
|||
Comprehensive income attributable to Westlake Chemical Corporation
|
|
$
|
409
|
|
|
$
|
914
|
|
|
$
|
1,432
|
|
|
|
Common Stock
|
|
Common Stock,
Held in Treasury
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||||||
|
|
Number of
Shares
|
|
Amount
|
|
Number of
Shares
|
|
At Cost
|
|
Additional
Paid-in
Capital
|
|
Retained
Earnings
|
|
Accumulated Other Comprehensive
Income (Loss)
|
|
Noncontrolling Interests
|
|
Total
|
||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
|
|
(in millions of dollars, except share amounts)
|
||||||||||||||||||||||||||||||||
Balances at December 31, 2016
|
|
134,651,380
|
|
|
$
|
1
|
|
|
5,726,377
|
|
|
$
|
(319
|
)
|
|
$
|
551
|
|
|
$
|
3,412
|
|
|
$
|
(121
|
)
|
|
$
|
368
|
|
|
$
|
3,892
|
|
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1,304
|
|
|
—
|
|
|
35
|
|
|
1,339
|
|
|||||||
Other comprehensive income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
128
|
|
|
5
|
|
|
133
|
|
|||||||
Shares issued—stock-based compensation
|
|
—
|
|
|
—
|
|
|
(493,502
|
)
|
|
17
|
|
|
(6
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
11
|
|
|||||||
Stock-based compensation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
14
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
14
|
|
|||||||
Dividends declared
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(103
|
)
|
|
—
|
|
|
—
|
|
|
(103
|
)
|
|||||||
Distributions to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(28
|
)
|
|
(28
|
)
|
|||||||
Issuance of Westlake Chemical Partners LP common units
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4
|
)
|
|
—
|
|
|
—
|
|
|
115
|
|
|
111
|
|
|||||||
Balances at December 31, 2017
|
|
134,651,380
|
|
|
1
|
|
|
5,232,875
|
|
|
(302
|
)
|
|
555
|
|
|
4,613
|
|
|
7
|
|
|
495
|
|
|
5,369
|
|
|||||||
Cumulative effect of accounting change
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|
—
|
|
|
—
|
|
|
1
|
|
|||||||
Reclassification of certain tax effects to retained earnings
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(13
|
)
|
|
13
|
|
|
—
|
|
|
—
|
|
|||||||
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
996
|
|
|
—
|
|
|
38
|
|
|
1,034
|
|
|||||||
Other comprehensive loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(82
|
)
|
|
(2
|
)
|
|
(84
|
)
|
|||||||
Common stock repurchased
|
|
—
|
|
|
—
|
|
|
1,368,881
|
|
|
(106
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(106
|
)
|
|||||||
Shares issued—stock-based compensation
|
|
—
|
|
|
—
|
|
|
(418,631
|
)
|
|
26
|
|
|
(17
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
9
|
|
|||||||
Stock-based compensation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
18
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
18
|
|
|||||||
Dividends declared
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(120
|
)
|
|
—
|
|
|
—
|
|
|
(120
|
)
|
|||||||
Distributions to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(45
|
)
|
|
(45
|
)
|
|||||||
Balances at December 31, 2018
|
|
134,651,380
|
|
|
1
|
|
|
6,183,125
|
|
|
(382
|
)
|
|
556
|
|
|
5,477
|
|
|
(62
|
)
|
|
486
|
|
|
6,076
|
|
|||||||
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
421
|
|
|
—
|
|
|
41
|
|
|
462
|
|
|||||||
Other comprehensive income (loss)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(12
|
)
|
|
1
|
|
|
(11
|
)
|
|||||||
Common stock repurchased
|
|
—
|
|
|
—
|
|
|
517,712
|
|
|
(30
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(30
|
)
|
|||||||
Shares issued—stock-based compensation
|
|
—
|
|
|
—
|
|
|
(434,228
|
)
|
|
35
|
|
|
(25
|
)
|
|
(9
|
)
|
|
—
|
|
|
—
|
|
|
1
|
|
|||||||
Stock-based compensation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
24
|
|
|
|
|
|
—
|
|
|
—
|
|
|
24
|
|
|||||||
Dividends declared
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(132
|
)
|
|
—
|
|
|
—
|
|
|
(132
|
)
|
|||||||
Distributions to noncontrolling interests
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(50
|
)
|
|
(50
|
)
|
|||||||
Issuance of Westlake Chemical Partners LP common units
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
—
|
|
|
—
|
|
|
65
|
|
|
63
|
|
|||||||
Balances at December 31, 2019
|
|
134,651,380
|
|
|
$
|
1
|
|
|
6,266,609
|
|
|
$
|
(377
|
)
|
|
$
|
553
|
|
|
$
|
5,757
|
|
|
$
|
(74
|
)
|
|
$
|
543
|
|
|
$
|
6,403
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||
|
|
|
|
|
|
|
||||||
|
|
(in millions of dollars)
|
||||||||||
Cash flows from operating activities
|
|
|
|
|
|
|
||||||
Net income
|
|
$
|
462
|
|
|
$
|
1,034
|
|
|
$
|
1,339
|
|
Adjustments to reconcile net income to net cash provided by operating activities
|
|
|
|
|
|
|
||||||
Depreciation and amortization
|
|
713
|
|
|
641
|
|
|
601
|
|
|||
Stock-based compensation expense
|
|
25
|
|
|
22
|
|
|
23
|
|
|||
Loss from disposition and write-off of property, plant and equipment
|
|
49
|
|
|
44
|
|
|
22
|
|
|||
Deferred income taxes
|
|
54
|
|
|
62
|
|
|
(534
|
)
|
|||
Other losses (gains), net
|
|
1
|
|
|
(20
|
)
|
|
(3
|
)
|
|||
Changes in operating assets and liabilities, net of effect of business acquisitions
|
|
|
|
|
|
|
||||||
Accounts receivable
|
|
59
|
|
|
(58
|
)
|
|
(40
|
)
|
|||
Inventories
|
|
112
|
|
|
(123
|
)
|
|
(32
|
)
|
|||
Prepaid expenses and other current assets
|
|
(1
|
)
|
|
(1
|
)
|
|
26
|
|
|||
Accounts payable
|
|
(89
|
)
|
|
(100
|
)
|
|
86
|
|
|||
Accrued and other liabilities
|
|
(13
|
)
|
|
(8
|
)
|
|
115
|
|
|||
Other, net
|
|
(71
|
)
|
|
(84
|
)
|
|
(75
|
)
|
|||
Net cash provided by operating activities
|
|
1,301
|
|
|
1,409
|
|
|
1,528
|
|
|||
Cash flows from investing activities
|
|
|
|
|
|
|
||||||
Acquisition of businesses, net of cash acquired
|
|
(314
|
)
|
|
—
|
|
|
(13
|
)
|
|||
Additions to property, plant and equipment
|
|
(787
|
)
|
|
(702
|
)
|
|
(577
|
)
|
|||
Additions to investments in unconsolidated subsidiaries
|
|
(862
|
)
|
|
(68
|
)
|
|
(66
|
)
|
|||
Other, net
|
|
9
|
|
|
16
|
|
|
4
|
|
|||
Net cash used for investing activities
|
|
(1,954
|
)
|
|
(754
|
)
|
|
(652
|
)
|
|||
Cash flows from financing activities
|
|
|
|
|
|
|
||||||
Dividends paid
|
|
(132
|
)
|
|
(120
|
)
|
|
(103
|
)
|
|||
Distributions to noncontrolling interests
|
|
(50
|
)
|
|
(45
|
)
|
|
(28
|
)
|
|||
Proceeds from debt issuance, net
|
|
784
|
|
|
—
|
|
|
—
|
|
|||
Proceeds from notes payable
|
|
20
|
|
|
14
|
|
|
978
|
|
|||
Net proceeds from issuance of Westlake Chemical Partners LP common units
|
|
63
|
|
|
—
|
|
|
111
|
|
|||
Repayment of term loan
|
|
—
|
|
|
—
|
|
|
(150
|
)
|
|||
Repayment of revolver
|
|
—
|
|
|
—
|
|
|
(550
|
)
|
|||
Redemption and repayment of notes payable
|
|
(18
|
)
|
|
(1,179
|
)
|
|
(257
|
)
|
|||
Repurchase of common stock for treasury
|
|
(30
|
)
|
|
(106
|
)
|
|
—
|
|
|||
Other
|
|
(7
|
)
|
|
9
|
|
|
5
|
|
|||
Net cash provided by (used for) financing activities
|
|
630
|
|
|
(1,427
|
)
|
|
6
|
|
|||
Effect of exchange rate changes on cash, cash equivalents and restricted cash
|
|
(2
|
)
|
|
(7
|
)
|
|
26
|
|
|||
Net increase (decrease) in cash, cash equivalents and restricted cash
|
|
(25
|
)
|
|
(779
|
)
|
|
908
|
|
|||
Cash, cash equivalents and restricted cash at beginning of the year
|
|
775
|
|
|
1,554
|
|
|
646
|
|
|||
Cash, cash equivalents and restricted cash at end of the year
|
|
$
|
750
|
|
|
$
|
775
|
|
|
$
|
1,554
|
|
Classification
|
|
Years
|
|
Buildings and improvements
|
|
40
|
|
Plant and equipment
|
|
10-25
|
|
Other
|
|
3-15
|
Operating Lease Assets and Liabilities
|
|
Balance Sheet Location
|
|
Amounts Recorded in the Consolidated Balance Sheet January 1, 2019
|
||
Right-of-use assets
|
|
Operating lease right-of-use assets
|
|
$
|
421
|
|
Current lease liabilities
|
|
Accrued and other liabilities
|
|
(94
|
)
|
|
Non-current lease liabilities
|
|
Operating lease liabilities
|
|
(331
|
)
|
|
Deferred rent
|
|
Other liabilities
|
|
4
|
|
Cash
|
|
$
|
10
|
|
Accounts receivable
|
|
53
|
|
|
Inventories
|
|
40
|
|
|
Prepaid expenses and other current assets
|
|
7
|
|
|
Property, plant and equipment
|
|
75
|
|
|
Operating lease right-of-use assets
|
|
3
|
|
|
Intangible assets:
|
|
|
||
Customer relationships (weighted average lives of 17 years)
|
|
65
|
|
|
Technology (weighted average lives of 14 years)
|
|
40
|
|
|
Trade name (life of 15 years)
|
|
25
|
|
|
Other assets
|
|
12
|
|
|
Total assets acquired
|
|
330
|
|
|
Accounts payable
|
|
57
|
|
|
Accrued and other liabilities
|
|
18
|
|
|
Deferred income taxes
|
|
31
|
|
|
Pension and other post-retirement benefits
|
|
4
|
|
|
Operating lease liabilities
|
|
3
|
|
|
Other long-term liabilities
|
|
8
|
|
|
Total liabilities assumed
|
|
121
|
|
|
Total identifiable net assets acquired
|
|
209
|
|
|
Goodwill
|
|
40
|
|
|
Total purchase consideration
|
|
$
|
249
|
|
|
|
2019
|
|
2018
|
||||
Trade customers
|
|
$
|
948
|
|
|
$
|
969
|
|
Related parties
|
|
12
|
|
|
6
|
|
||
Allowance for doubtful accounts
|
|
(22
|
)
|
|
(23
|
)
|
||
|
|
938
|
|
|
952
|
|
||
Federal and state taxes
|
|
59
|
|
|
57
|
|
||
Other
|
|
39
|
|
|
28
|
|
||
Accounts receivable, net
|
|
$
|
1,036
|
|
|
$
|
1,037
|
|
|
|
2019
|
|
2018
|
||||
Finished products
|
|
$
|
568
|
|
|
$
|
657
|
|
Feedstock, additives, chemicals and other raw materials
|
|
210
|
|
|
203
|
|
||
Materials and supplies
|
|
158
|
|
|
154
|
|
||
Inventories
|
|
$
|
936
|
|
|
$
|
1,014
|
|
|
|
2019
|
|
2018
|
||||
Land
|
|
$
|
198
|
|
|
$
|
193
|
|
Buildings and improvements
|
|
608
|
|
|
544
|
|
||
Plant and equipment
|
|
8,227
|
|
|
7,568
|
|
||
Other
|
|
496
|
|
|
437
|
|
||
|
|
9,529
|
|
|
8,742
|
|
||
Less: Accumulated depreciation
|
|
(3,168
|
)
|
|
(2,720
|
)
|
||
|
|
6,361
|
|
|
6,022
|
|
||
Construction in progress
|
|
551
|
|
|
573
|
|
||
Property, plant and equipment, net
|
|
$
|
6,912
|
|
|
$
|
6,595
|
|
|
|
December 31,
2019 |
||
Operating Leases
|
|
|
||
Right-of-use assets
|
|
$
|
443
|
|
|
|
|
||
Accrued and other liabilities
|
|
$
|
93
|
|
Operating lease liabilities
|
|
355
|
|
|
Total operating lease liabilities
|
|
$
|
448
|
|
|
|
|
||
Weighted Average Remaining Term (in years)
|
|
8
|
|
|
Weighted Average Lease Discount Rate
|
|
3.5
|
%
|
|
|
December 31,
2019 |
||
Operating lease cost (1)
|
|
$
|
113
|
|
Short-term lease cost
|
|
58
|
|
|
Total operating lease cost
|
|
$
|
171
|
|
(1)
|
Includes fixed lease payments for operating leases recorded in the consolidated balance sheet.
|
|
|
Operating Leases
|
||
2020
|
|
$
|
106
|
|
2021
|
|
83
|
|
|
2022
|
|
69
|
|
|
2023
|
|
55
|
|
|
2024
|
|
43
|
|
|
Thereafter
|
|
189
|
|
|
Total lease payments
|
|
545
|
|
|
Less: imputed interest
|
|
(97
|
)
|
|
Present value of lease liabilities
|
|
$
|
448
|
|
|
|
Operating Leases
|
||
2019
|
|
$
|
94
|
|
2020
|
|
89
|
|
|
2021
|
|
70
|
|
|
2022
|
|
56
|
|
|
2023
|
|
42
|
|
|
Thereafter
|
|
152
|
|
|
Total lease payments
|
|
$
|
503
|
|
|
|
Olefins Segment
|
|
Vinyls Segment
|
|
Total
|
||||||
Balance at December 31, 2017
|
|
$
|
30
|
|
|
$
|
982
|
|
|
$
|
1,012
|
|
Effects of changes in foreign exchange rates
|
|
—
|
|
|
(10
|
)
|
|
(10
|
)
|
|||
Balance at December 31, 2018
|
|
30
|
|
|
972
|
|
|
1,002
|
|
|||
Goodwill acquired during the year
|
|
—
|
|
|
67
|
|
|
67
|
|
|||
Effects of changes in foreign exchange rates
|
|
—
|
|
|
5
|
|
|
5
|
|
|||
Balance at December 31, 2019
|
|
$
|
30
|
|
|
$
|
1,044
|
|
|
$
|
1,074
|
|
|
|
2019
|
|
2018
|
|
Weighted
Average
Life
|
||||||||||||||||||||
|
|
Cost
|
|
Accumulated
Amortization
|
|
Net
|
|
Cost
|
|
Accumulated
Amortization
|
|
Net
|
|
|||||||||||||
Customer relationships
|
|
$
|
832
|
|
|
$
|
(309
|
)
|
|
$
|
523
|
|
|
$
|
745
|
|
|
$
|
(220
|
)
|
|
$
|
525
|
|
|
11
|
Other intangible assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Licenses and intellectual property
|
|
172
|
|
|
(79
|
)
|
|
93
|
|
|
122
|
|
|
(65
|
)
|
|
57
|
|
|
13
|
||||||
Trademarks
|
|
120
|
|
|
(37
|
)
|
|
83
|
|
|
90
|
|
|
(26
|
)
|
|
64
|
|
|
13
|
||||||
Other
|
|
35
|
|
|
(24
|
)
|
|
11
|
|
|
35
|
|
|
(22
|
)
|
|
13
|
|
|
10
|
||||||
Total other intangible assets
|
|
$
|
327
|
|
|
$
|
(140
|
)
|
|
$
|
187
|
|
|
$
|
247
|
|
|
$
|
(113
|
)
|
|
$
|
134
|
|
|
|
|
Investment in LACC
|
||
Balance at December 31, 2018
|
$
|
183
|
|
Cash contributions
|
45
|
|
|
Additional interest purchased
|
817
|
|
|
Depreciation and amortization
|
(7
|
)
|
|
Balance at December 31, 2019
|
$
|
1,038
|
|
|
|
December 31,
2019 |
|
December 31,
2018 |
||||
Accounts payable—third parties
|
|
$
|
435
|
|
|
$
|
504
|
|
Accounts payable to related parties
|
|
12
|
|
|
2
|
|
||
Notes payable
|
|
26
|
|
|
1
|
|
||
Accounts payable
|
|
$
|
473
|
|
|
$
|
507
|
|
|
|
December 31, 2019
|
|
December 31, 2018
|
||||||||||||||||||||
|
|
Principal Amount
|
|
Unamortized Discount and Debt Issuance Costs
|
|
Net Long-Term Debt
|
|
Principal Amount
|
|
Unamortized Discount and Debt Issuance Costs
|
|
Net Long-Term Debt
|
||||||||||||
3.60% senior notes due 2022 (the "3.60% 2022 Senior Notes")
|
|
$
|
250
|
|
|
$
|
(1
|
)
|
|
$
|
249
|
|
|
$
|
250
|
|
|
$
|
(1
|
)
|
|
$
|
249
|
|
3.60% senior notes due 2026 (the "3.60% 2026 Senior Notes")
|
|
750
|
|
|
(8
|
)
|
|
742
|
|
|
750
|
|
|
(9
|
)
|
|
741
|
|
||||||
Loan related to tax-exempt waste disposal revenue bonds due 2027
|
|
11
|
|
|
—
|
|
|
11
|
|
|
11
|
|
|
—
|
|
|
11
|
|
||||||
6 ½% senior notes due 2029 (the "6 ½% 2029 GO Zone Senior Notes")
|
|
100
|
|
|
(1
|
)
|
|
99
|
|
|
100
|
|
|
(1
|
)
|
|
99
|
|
||||||
6 ½% senior notes due 2035 (the "6 ½% 2035 GO Zone Senior Notes")
|
|
89
|
|
|
(1
|
)
|
|
88
|
|
|
89
|
|
|
(1
|
)
|
|
88
|
|
||||||
6 ½% senior notes due 2035 (the "6 ½% 2035 IKE Zone Senior Notes")
|
|
65
|
|
|
—
|
|
|
65
|
|
|
65
|
|
|
—
|
|
|
65
|
|
||||||
5.0% senior notes due 2046 (the "5.0% 2046 Senior Notes")
|
|
700
|
|
|
(23
|
)
|
|
677
|
|
|
700
|
|
|
(24
|
)
|
|
676
|
|
||||||
4.375% senior notes due 2047 (the "4.375% 2047 Senior Notes")
|
|
500
|
|
|
(9
|
)
|
|
491
|
|
|
500
|
|
|
(9
|
)
|
|
491
|
|
||||||
3.50% senior notes due 2032 (the "3.50% 2032 GO Zone Refunding Senior Notes")
|
|
250
|
|
|
(1
|
)
|
|
249
|
|
|
250
|
|
|
(2
|
)
|
|
248
|
|
||||||
1.625% senior notes due 2029 (the "1.625% 2029 Senior Notes")
|
|
785
|
|
|
(11
|
)
|
|
774
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Long-term debt
|
|
$
|
3,500
|
|
|
$
|
(55
|
)
|
|
$
|
3,445
|
|
|
$
|
2,715
|
|
|
$
|
(47
|
)
|
|
$
|
2,668
|
|
|
|
Pension and Other Post-Retirement Benefits Liability, Net of Tax
|
|
Cumulative Foreign Currency
Exchange, Net of Tax
|
|
Total
|
||||||
Balances at December 31, 2017
|
|
$
|
43
|
|
|
$
|
(36
|
)
|
|
$
|
7
|
|
Other comprehensive income (loss) before reclassifications
|
|
(14
|
)
|
|
(57
|
)
|
|
(71
|
)
|
|||
Amounts reclassified from accumulated other comprehensive income (loss)
|
|
(11
|
)
|
|
—
|
|
|
(11
|
)
|
|||
Reclassification of certain tax effects to retained earnings (1)
|
|
9
|
|
|
4
|
|
|
13
|
|
|||
Net other comprehensive loss attributable to Westlake Chemical Corporation
|
|
(16
|
)
|
|
(53
|
)
|
|
(69
|
)
|
|||
Balances at December 31, 2018
|
|
27
|
|
|
(89
|
)
|
|
(62
|
)
|
|||
Other comprehensive income (loss) before reclassifications
|
|
(24
|
)
|
|
12
|
|
|
(12
|
)
|
|||
Amounts reclassified from accumulated other comprehensive income (loss)
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
Net other comprehensive income (loss) attributable to Westlake Chemical Corporation
|
|
(24
|
)
|
|
12
|
|
|
(12
|
)
|
|||
Balances at December 31, 2019
|
|
$
|
3
|
|
|
$
|
(77
|
)
|
|
$
|
(74
|
)
|
(1)
|
In 2018, the Company reclassified certain income tax effects to retained earnings upon adoption of ASU No. 2018-02. See Note 1 (Income taxes) for additional information.
|
Details about Accumulated Other Comprehensive Income (Loss) Components
|
|
Location of Reclassification
(Income (Expense)) in
Consolidated Statements
of Operations
|
|
Year Ended December 31,
|
||||||||||
|
2019
|
|
2018
|
|
2017
|
|||||||||
Amortization of pension and other post-retirement net loss
|
|
(1)
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
(2
|
)
|
Pension settlement gain
|
|
(1)
|
|
—
|
|
|
14
|
|
|
—
|
|
|||
Income tax benefit (provision) on pension and other post-retirement benefits
|
|
Provision for (benefit from) income taxes
|
|
—
|
|
|
(3
|
)
|
|
—
|
|
|||
Total reclassifications for the period
|
|
|
|
$
|
—
|
|
|
$
|
11
|
|
|
$
|
(2
|
)
|
(1)
|
These accumulated other comprehensive income (loss) components are included in the computation of net periodic benefit cost and reflected in other income, net in the consolidated statements of operations. See Note 14 for additional information on the pension settlement gain recognized in 2018.
|
|
|
2019
|
|
2018
|
||||||||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||
Change in benefit obligation
|
|
|
|
|
|
|
|
|
||||||||
Benefit obligation, beginning of year
|
|
$
|
648
|
|
|
$
|
136
|
|
|
$
|
807
|
|
|
$
|
142
|
|
Service cost
|
|
3
|
|
|
2
|
|
|
3
|
|
|
2
|
|
||||
Interest cost
|
|
23
|
|
|
3
|
|
|
24
|
|
|
3
|
|
||||
Actuarial loss (gain)
|
|
80
|
|
|
14
|
|
|
(43
|
)
|
|
—
|
|
||||
Benefits paid
|
|
(51
|
)
|
|
(4
|
)
|
|
(40
|
)
|
|
(4
|
)
|
||||
Plan amendments
|
|
—
|
|
|
(4
|
)
|
|
—
|
|
|
—
|
|
||||
Settlements
|
|
—
|
|
|
(1
|
)
|
|
(103
|
)
|
|
—
|
|
||||
Foreign exchange effects
|
|
—
|
|
|
(2
|
)
|
|
—
|
|
|
(7
|
)
|
||||
Benefit obligation, end of year
|
|
$
|
703
|
|
|
$
|
144
|
|
|
$
|
648
|
|
|
$
|
136
|
|
|
|
|
|
|
|
|
|
|
||||||||
Change in plan assets
|
|
|
|
|
|
|
|
|
||||||||
Fair value of plan assets, beginning of year
|
|
$
|
486
|
|
|
$
|
17
|
|
|
$
|
650
|
|
|
$
|
18
|
|
Actual return
|
|
92
|
|
|
1
|
|
|
(22
|
)
|
|
—
|
|
||||
Employer contribution
|
|
2
|
|
|
—
|
|
|
3
|
|
|
1
|
|
||||
Benefits paid
|
|
(51
|
)
|
|
—
|
|
|
(40
|
)
|
|
(1
|
)
|
||||
Administrative expenses paid
|
|
(3
|
)
|
|
—
|
|
|
(2
|
)
|
|
—
|
|
||||
Settlements
|
|
—
|
|
|
—
|
|
|
(103
|
)
|
|
—
|
|
||||
Foreign exchange effects
|
|
—
|
|
|
1
|
|
|
—
|
|
|
(1
|
)
|
||||
Fair value of plan assets, end of year
|
|
$
|
526
|
|
|
$
|
19
|
|
|
$
|
486
|
|
|
$
|
17
|
|
Funded status, end of year
|
|
$
|
(177
|
)
|
|
$
|
(125
|
)
|
|
$
|
(162
|
)
|
|
$
|
(119
|
)
|
|
|
2019
|
|
2018
|
||||||||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||
Amounts recognized in the consolidated balance sheet at December 31
|
|
|
|
|
|
|
|
|
||||||||
Current liabilities
|
|
$
|
(2
|
)
|
|
$
|
(2
|
)
|
|
$
|
(2
|
)
|
|
$
|
(3
|
)
|
Noncurrent liabilities
|
|
(175
|
)
|
|
(123
|
)
|
|
(160
|
)
|
|
(116
|
)
|
||||
Net amount recognized
|
|
$
|
(177
|
)
|
|
$
|
(125
|
)
|
|
$
|
(162
|
)
|
|
$
|
(119
|
)
|
|
|
2019
|
|
2018
|
||||||||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||
Amounts recognized in accumulated other comprehensive income (loss)
|
|
|
|
|
|
|
|
|
||||||||
Net loss (gain)
|
|
$
|
(16
|
)
|
|
$
|
22
|
|
|
$
|
(36
|
)
|
|
$
|
9
|
|
Prior service cost
|
|
—
|
|
|
(4
|
)
|
|
—
|
|
|
—
|
|
||||
Total before tax (1)
|
|
$
|
(16
|
)
|
|
$
|
18
|
|
|
$
|
(36
|
)
|
|
$
|
9
|
|
(1)
|
After-tax totals for pension benefits were $0 and $22 for 2019 and 2018, respectively, and are reflected in stockholders' equity as accumulated other comprehensive income (loss).
|
|
|
2019
|
|
2018
|
||||||||||||
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
|
U.S. Plans
|
|
Non-U.S. Plans
|
||||||||
Information for pension plans with an accumulated benefit obligation in excess of plan assets
|
|
|
|
|
|
|
|
|
||||||||
Projected benefit obligation
|
|
$
|
(703
|
)
|
|
$
|
(143
|
)
|
|
$
|
(648
|
)
|
|
$
|
(128
|
)
|
Accumulated benefit obligation
|
|
(703
|
)
|
|
(138
|
)
|
|
(648
|
)
|
|
(125
|
)
|
||||
Fair value of plan assets
|
|
526
|
|
|
18
|
|
|
486
|
|
|
10
|
|
|
|
Year Ended December 31,
|
||||||||||||||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||||||||||||||
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
||||||||||||
Components of net periodic benefit cost
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Service cost
|
|
$
|
3
|
|
|
$
|
2
|
|
|
$
|
3
|
|
|
$
|
2
|
|
|
$
|
3
|
|
|
$
|
2
|
|
Administrative expenses
|
|
4
|
|
|
—
|
|
|
3
|
|
|
—
|
|
|
2
|
|
|
—
|
|
||||||
Interest cost
|
|
23
|
|
|
3
|
|
|
24
|
|
|
3
|
|
|
25
|
|
|
2
|
|
||||||
Expected return on plan assets
|
|
(33
|
)
|
|
(1
|
)
|
|
(42
|
)
|
|
(1
|
)
|
|
(40
|
)
|
|
(1
|
)
|
||||||
Net amortization
|
|
—
|
|
|
—
|
|
|
(1
|
)
|
|
1
|
|
|
1
|
|
|
1
|
|
||||||
Settlement gain
|
|
—
|
|
|
—
|
|
|
(14
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Net periodic benefit cost (gain)
|
|
$
|
(3
|
)
|
|
$
|
4
|
|
|
$
|
(27
|
)
|
|
$
|
5
|
|
|
$
|
(9
|
)
|
|
$
|
4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Other changes in plan assets and benefit obligation recognized in other comprehensive income (OCI)
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net loss (gain) emerging
|
|
$
|
20
|
|
|
$
|
13
|
|
|
$
|
20
|
|
|
$
|
1
|
|
|
$
|
(18
|
)
|
|
$
|
—
|
|
Settlement gain
|
|
—
|
|
|
—
|
|
|
14
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Effect of plan change
|
|
—
|
|
|
(4
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Amortization of net gain (loss)
|
|
—
|
|
|
—
|
|
|
1
|
|
|
(1
|
)
|
|
(1
|
)
|
|
(1
|
)
|
||||||
Total recognized in OCI
|
|
$
|
20
|
|
|
$
|
9
|
|
|
$
|
35
|
|
|
$
|
—
|
|
|
$
|
(19
|
)
|
|
$
|
(1
|
)
|
Total net periodic benefit cost and OCI
|
|
$
|
17
|
|
|
$
|
13
|
|
|
$
|
8
|
|
|
$
|
5
|
|
|
$
|
(28
|
)
|
|
$
|
3
|
|
|
|
2019
|
|
2018
|
|
2017
|
||||||||||||
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
|
U.S.
Plans
|
|
Non-U.S.
Plans
|
||||||
Weighted average assumptions used to determine benefit obligations at December 31
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Discount rate
|
|
3.0
|
%
|
|
1.3
|
%
|
|
4.1
|
%
|
|
2.0
|
%
|
|
3.4
|
%
|
|
1.8
|
%
|
Rate of compensation increase
|
|
—
|
%
|
|
2.6
|
%
|
|
—
|
%
|
|
2.6
|
%
|
|
—
|
%
|
|
2.6
|
%
|
Weighted average assumptions used to determine net periodic benefit costs for years ended December 31
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Discount rate for benefit obligations
|
|
4.1
|
%
|
|
2.0
|
%
|
|
3.4
|
%
|
|
1.8
|
%
|
|
3.8
|
%
|
|
1.8
|
%
|
Discount rate for service cost
|
|
4.2
|
%
|
|
2.2
|
%
|
|
3.8
|
%
|
|
2.0
|
%
|
|
4.1
|
%
|
|
1.9
|
%
|
Discount rate for interest cost
|
|
3.7
|
%
|
|
2.2
|
%
|
|
3.3
|
%
|
|
2.0
|
%
|
|
3.2
|
%
|
|
2.0
|
%
|
Expected return on plan assets
|
|
7.0
|
%
|
|
4.0
|
%
|
|
7.0
|
%
|
|
3.8
|
%
|
|
6.8
|
%
|
|
3.8
|
%
|
Rate of compensation increase
|
|
—
|
%
|
|
2.6
|
%
|
|
—
|
%
|
|
2.6
|
%
|
|
—
|
%
|
|
2.6
|
%
|
|
|
2019
|
||||||||||||||||||||||
|
|
U.S. Plans
|
|
Non U.S. Plans
|
||||||||||||||||||||
|
|
Level 1
|
|
Level 2
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Total
|
||||||||||||
Cash and common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Cash and cash equivalents
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
6
|
|
|
$
|
—
|
|
|
$
|
6
|
|
Common stock
|
|
15
|
|
|
—
|
|
|
15
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Collective investment trust and
mutual funds—Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Large-cap funds (1)
|
|
49
|
|
|
112
|
|
|
161
|
|
|
—
|
|
|
1
|
|
|
1
|
|
||||||
Small-cap funds (2)
|
|
8
|
|
|
14
|
|
|
22
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
International funds (3)
|
|
75
|
|
|
45
|
|
|
120
|
|
|
—
|
|
|
5
|
|
|
5
|
|
||||||
Collective investment trust and mutual funds—Fixed income:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Bond funds (4)
|
|
100
|
|
|
98
|
|
|
198
|
|
|
—
|
|
|
7
|
|
|
7
|
|
||||||
Short-term investment funds
|
|
—
|
|
|
10
|
|
|
10
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
|
$
|
247
|
|
|
$
|
279
|
|
|
$
|
526
|
|
|
$
|
6
|
|
|
$
|
13
|
|
|
$
|
19
|
|
|
|
2018
|
||||||||||||||||||||||
|
|
U.S. Plans
|
|
Non U.S. Plans
|
||||||||||||||||||||
|
|
Level 1
|
|
Level 2
|
|
Total
|
|
Level 1
|
|
Level 2
|
|
Total
|
||||||||||||
Cash and common stock:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Cash and cash equivalents
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
5
|
|
|
$
|
—
|
|
|
$
|
5
|
|
Common stock
|
|
13
|
|
|
—
|
|
|
13
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Collective investment trust and mutual funds—Equity securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Large-cap funds (1)
|
|
44
|
|
|
98
|
|
|
142
|
|
|
—
|
|
|
1
|
|
|
1
|
|
||||||
Small-cap funds (2)
|
|
6
|
|
|
13
|
|
|
19
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
International funds (3)
|
|
64
|
|
|
38
|
|
|
102
|
|
|
—
|
|
|
5
|
|
|
5
|
|
||||||
Collective investment trust and mutual funds—Fixed income:
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Bond funds (4)
|
|
96
|
|
|
102
|
|
|
198
|
|
|
—
|
|
|
6
|
|
|
6
|
|
||||||
Short-term investment funds
|
|
—
|
|
|
12
|
|
|
12
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
|
|
$
|
223
|
|
|
$
|
263
|
|
|
$
|
486
|
|
|
$
|
5
|
|
|
$
|
12
|
|
|
$
|
17
|
|
(1)
|
Substantially all of the assets of these funds are invested in large-cap U.S. companies. The remainder of the assets of these funds is invested in cash reserves.
|
(2)
|
Substantially all of the assets of these funds are invested in small-cap U.S. companies. The remainder of the assets of these funds is invested in cash reserves.
|
(3)
|
Substantially all of the assets of these funds are invested in international companies in developed markets (excluding the U.S.). The remainder of the assets of these funds is invested in cash reserves.
|
(4)
|
This category represents investment grade bonds of U.S. issuers, including U.S. Treasury notes.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||
|
|
Non-U.S.
Plans
|
|
Non-U.S.
Plans
|
|
Non-U.S.
Plans
|
||||||
Contributions to multi-employer plans (1)
|
|
$
|
9
|
|
|
$
|
7
|
|
|
$
|
8
|
|
(1)
|
The plan information for both the Pensionskasse der Mitarbeiter der Hoechst-Gruppe VVaG and Pensionskasse der Wacker-Chemie GmbH VVaG plans is publicly available. The plans provide fixed, monthly retirement payments on the basis of the credits earned by the participating employees. To the extent that the plans are underfunded, future contributions to the plans may increase and may be used to fund retirement benefits for employees related to other employers. The Company does not consider either of its multi-employer plans individually significant.
|
|
|
2019
|
|
2018
|
||||||||||||
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
||||||||
Change in benefit obligation
|
|
|
|
|
|
|
|
|
||||||||
Benefit obligation, beginning of year
|
|
$
|
67
|
|
|
$
|
3
|
|
|
$
|
73
|
|
|
$
|
3
|
|
Service cost
|
|
1
|
|
|
—
|
|
|
1
|
|
|
—
|
|
||||
Interest cost
|
|
2
|
|
|
—
|
|
|
2
|
|
|
—
|
|
||||
Actuarial loss (gain)
|
|
3
|
|
|
1
|
|
|
(1
|
)
|
|
—
|
|
||||
Benefits paid
|
|
(8
|
)
|
|
—
|
|
|
(8
|
)
|
|
—
|
|
||||
Benefit obligation, end of year
|
|
$
|
65
|
|
|
$
|
4
|
|
|
$
|
67
|
|
|
$
|
3
|
|
|
|
|
|
|
|
|
|
|
||||||||
Change in plan assets
|
|
|
|
|
|
|
|
|
||||||||
Fair value of plan assets, beginning of year
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Employer contribution
|
|
8
|
|
|
—
|
|
|
8
|
|
|
—
|
|
||||
Benefits paid
|
|
(8
|
)
|
|
—
|
|
|
(8
|
)
|
|
—
|
|
||||
Fair value of plan assets, end of year
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
Funded status, end of year
|
|
$
|
(65
|
)
|
|
$
|
(4
|
)
|
|
$
|
(67
|
)
|
|
$
|
(3
|
)
|
|
|
2019
|
|
2018
|
||||||||||||
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
||||||||
Amounts recognized in the consolidated balance sheet at December 31
|
|
|
|
|
|
|
|
|
||||||||
Current liabilities
|
|
$
|
(8
|
)
|
|
$
|
—
|
|
|
$
|
(8
|
)
|
|
$
|
—
|
|
Noncurrent liabilities
|
|
(57
|
)
|
|
(5
|
)
|
|
(59
|
)
|
|
(3
|
)
|
||||
Net amount recognized
|
|
$
|
(65
|
)
|
|
$
|
(5
|
)
|
|
$
|
(67
|
)
|
|
$
|
(3
|
)
|
|
|
2019
|
|
2018
|
||||||||||||
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
||||||||
Amounts recognized in accumulated other comprehensive income (loss)
|
|
|
|
|
|
|
|
|
||||||||
Net gain
|
|
$
|
(3
|
)
|
|
$
|
—
|
|
|
$
|
(6
|
)
|
|
$
|
—
|
|
Total before tax (1)
|
|
$
|
(3
|
)
|
|
$
|
—
|
|
|
$
|
(6
|
)
|
|
$
|
—
|
|
(1)
|
After-tax totals for post-retirement healthcare benefits were $3 and $5 for 2019 and 2018, respectively, and are reflected in stockholders' equity as accumulated other comprehensive income (loss).
|
|
|
Year Ended December 31,
|
||||||||||||||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||||||||||||||
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
||||||||||||
Components of net periodic benefit cost
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Service cost
|
|
$
|
1
|
|
|
$
|
—
|
|
|
$
|
1
|
|
|
$
|
—
|
|
|
$
|
1
|
|
|
$
|
—
|
|
Interest cost
|
|
2
|
|
|
—
|
|
|
2
|
|
|
—
|
|
|
2
|
|
|
—
|
|
||||||
Net amortization
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||||
Net periodic benefit cost
|
|
$
|
3
|
|
|
$
|
—
|
|
|
$
|
3
|
|
|
$
|
—
|
|
|
$
|
3
|
|
|
$
|
—
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Other changes in plan assets and benefit obligation recognized in OCI
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||
Net loss (gain) emerging
|
|
$
|
3
|
|
|
$
|
—
|
|
|
$
|
(1
|
)
|
|
$
|
(1
|
)
|
|
$
|
(1
|
)
|
|
$
|
—
|
|
Total recognized in OCI
|
|
$
|
3
|
|
|
$
|
—
|
|
|
$
|
(1
|
)
|
|
$
|
(1
|
)
|
|
$
|
(1
|
)
|
|
$
|
—
|
|
Total net periodic benefit cost and OCI
|
|
$
|
6
|
|
|
$
|
—
|
|
|
$
|
2
|
|
|
$
|
(1
|
)
|
|
$
|
2
|
|
|
$
|
—
|
|
|
|
2019
|
|
2018
|
|
2017
|
||||||||||||
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
|
U.S. Plans
|
|
Non-U.S.
Plans
|
||||||
Weighted average assumptions used to determine benefit obligations at December 31
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Discount rate
|
|
2.5
|
%
|
|
3.2
|
%
|
|
3.7
|
%
|
|
3.9
|
%
|
|
3.0
|
%
|
|
4.0
|
%
|
Health care cost trend rate
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
- Initial rate
|
|
6.8
|
%
|
|
5.7
|
%
|
|
7.0
|
%
|
|
5.8
|
%
|
|
7.3
|
%
|
|
6.2
|
%
|
- Ultimate rate
|
|
4.5
|
%
|
|
4.0
|
%
|
|
4.5
|
%
|
|
4.0
|
%
|
|
4.5
|
%
|
|
4.5
|
%
|
- Years to ultimate
|
|
10
|
|
|
21
|
|
|
11
|
|
|
22
|
|
|
11
|
|
|
12
|
|
Weighted average assumptions used to determine net periodic benefit costs for years ended December 31
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Discount rate for benefit obligations
|
|
3.7
|
%
|
|
3.9
|
%
|
|
3.0
|
%
|
|
3.6
|
%
|
|
3.3
|
%
|
|
3.3
|
%
|
Discount rate for service cost
|
|
4.0
|
%
|
|
3.9
|
%
|
|
3.4
|
%
|
|
3.6
|
%
|
|
3.8
|
%
|
|
3.3
|
%
|
Discount rate for interest cost
|
|
3.4
|
%
|
|
3.9
|
%
|
|
2.7
|
%
|
|
3.6
|
%
|
|
2.6
|
%
|
|
3.3
|
%
|
Health care cost trend rate
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
- Initial rate
|
|
7.0
|
%
|
|
5.8
|
%
|
|
7.0
|
%
|
|
6.1
|
%
|
|
6.8
|
%
|
|
6.8
|
%
|
- Ultimate rate
|
|
4.5
|
%
|
|
4.0
|
%
|
|
4.5
|
%
|
|
4.5
|
%
|
|
4.6
|
%
|
|
4.5
|
%
|
- Years to ultimate
|
|
10
|
|
|
21
|
|
|
10
|
|
|
11
|
|
|
11
|
|
|
12
|
|
|
|
Pension
Benefits
|
|
Other Post-
retirement
Benefits
|
||||
Estimated future benefit payments:
|
|
|
|
|
||||
Year 1
|
|
$
|
45
|
|
|
$
|
8
|
|
Year 2
|
|
45
|
|
|
8
|
|
||
Year 3
|
|
45
|
|
|
8
|
|
||
Year 4
|
|
47
|
|
|
8
|
|
||
Year 5
|
|
46
|
|
|
7
|
|
||
Years 6 to 10
|
|
233
|
|
|
22
|
|
|
|
Options
|
|
Weighted
Average
Exercise
Price
|
|
Weighted
Average
Remaining
Term
(Years)
|
|
Aggregate
Intrinsic
Value
|
|||||
Outstanding at December 31, 2018
|
|
1,115,954
|
|
|
$
|
54.82
|
|
|
|
|
|
||
Granted
|
|
296,598
|
|
|
79.83
|
|
|
|
|
|
|||
Exercised
|
|
(18,635
|
)
|
|
35.04
|
|
|
|
|
|
|||
Cancelled
|
|
(7,969
|
)
|
|
79.94
|
|
|
|
|
|
|||
Outstanding at December 31, 2019
|
|
1,385,948
|
|
|
$
|
60.29
|
|
|
5.9
|
|
$
|
23
|
|
Exercisable at December 31, 2019
|
|
888,093
|
|
|
$
|
47.64
|
|
|
4.5
|
|
$
|
22
|
|
Range of Prices
|
|
Options
Outstanding
|
|
Weighted
Average
Remaining
Contractual
Life (Years)
|
|
$10.26 - $30.05
|
|
264,334
|
|
|
1.0
|
$40.38 - $44.42
|
|
218,047
|
|
|
6.1
|
$45.70 - $61.87
|
|
295,620
|
|
|
6.5
|
$63.98 - $68.18
|
|
145,171
|
|
|
4.7
|
$79.83 - $107.75
|
|
462,776
|
|
|
8.8
|
|
|
Stock Option Grants
|
||||||||||
|
|
Year Ended December 31,
|
||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||
Weighted average fair value
|
|
$
|
21.02
|
|
|
$
|
28.94
|
|
|
$
|
15.84
|
|
Risk-free interest rate
|
|
2.5
|
%
|
|
2.7
|
%
|
|
2.1
|
%
|
|||
Expected life in years
|
|
5
|
|
|
5
|
|
|
5
|
|
|||
Expected volatility
|
|
28.9
|
%
|
|
27.6
|
%
|
|
29.2
|
%
|
|||
Expected dividend yield
|
|
1.2
|
%
|
|
0.7
|
%
|
|
1.2
|
%
|
|
|
Number of
Units
|
|
Weighted
Average
Grant Date
Fair Value
|
|||
Non-vested at December 31, 2018
|
|
702,789
|
|
|
$
|
65.79
|
|
Granted
|
|
205,517
|
|
|
77.59
|
|
|
Vested
|
|
(415,593
|
)
|
|
56.70
|
|
|
Forfeited
|
|
(29,430
|
)
|
|
73.28
|
|
|
Non-vested at December 31, 2019
|
|
463,283
|
|
|
$
|
78.69
|
|
|
|
Number of
Units
|
|
Weighted
Average
Grant Date
Fair Value
|
|||
Non-vested at December 31, 2018
|
|
—
|
|
|
$
|
—
|
|
Granted
|
|
78,328
|
|
|
114.38
|
|
|
Vested
|
|
—
|
|
|
—
|
|
|
Forfeited
|
|
(1,111
|
)
|
|
114.38
|
|
|
Non-vested at December 31, 2019
|
|
77,217
|
|
|
$
|
114.38
|
|
|
|
Year Ended December 31, 2019
Performance Stock Units
|
||
Risk-free interest rate
|
|
2.5
|
%
|
|
Expected life in years
|
|
2.88
|
|
|
Expected volatility of Westlake Chemical Corporation common stock
|
|
30.3
|
%
|
|
Expected volatility of peer companies
|
|
14.5% - 47.8%
|
|
|
Average correlation coefficient of peer companies
|
|
0.49
|
|
|
Grant date fair value
|
|
$
|
114.38
|
|
|
|
Number of
Units
|
|
Weighted Average Fair Value
|
|||
Non-vested at December 31, 2018
|
|
49,528
|
|
|
$
|
66.46
|
|
Vested
|
|
(49,292
|
)
|
|
68.22
|
|
|
Cancelled
|
|
(236
|
)
|
|
76.77
|
|
|
Non-vested at December 31, 2019
|
|
—
|
|
|
—
|
|
|
|
2019
|
|
2018
|
||||||||||||
|
|
Carrying
Value
|
|
Fair
Value
|
|
Carrying
Value
|
|
Fair
Value
|
||||||||
3.60% 2022 Senior Notes
|
|
$
|
249
|
|
|
$
|
255
|
|
|
$
|
249
|
|
|
$
|
248
|
|
3.60% 2026 Senior Notes
|
|
742
|
|
|
777
|
|
|
741
|
|
|
692
|
|
||||
Loan related to tax-exempt waste disposal revenue bonds due 2027
|
|
11
|
|
|
11
|
|
|
11
|
|
|
11
|
|
||||
6 ½% 2029 GO Zone Senior Notes
|
|
99
|
|
|
103
|
|
|
99
|
|
|
106
|
|
||||
6 ½% 2035 GO Zone Senior Notes
|
|
88
|
|
|
92
|
|
|
88
|
|
|
95
|
|
||||
6 ½% 2035 IKE Zone Senior Notes
|
|
65
|
|
|
68
|
|
|
65
|
|
|
69
|
|
||||
5.0% 2046 Senior Notes
|
|
677
|
|
|
761
|
|
|
676
|
|
|
641
|
|
||||
4.375% 2047 Senior Notes
|
|
491
|
|
|
505
|
|
|
491
|
|
|
417
|
|
||||
3.50% 2032 GO Zone Refunding Senior Notes
|
|
249
|
|
|
267
|
|
|
248
|
|
|
233
|
|
||||
1.625% 2029 Senior Notes
|
|
774
|
|
|
785
|
|
|
—
|
|
|
—
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||
Domestic
|
|
$
|
460
|
|
|
$
|
1,087
|
|
|
$
|
917
|
|
Foreign
|
|
110
|
|
|
247
|
|
|
164
|
|
|||
|
|
$
|
570
|
|
|
$
|
1,334
|
|
|
$
|
1,081
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||
Current
|
|
|
|
|
|
|
||||||
Federal
|
|
$
|
20
|
|
|
$
|
158
|
|
|
$
|
231
|
|
State
|
|
9
|
|
|
28
|
|
|
18
|
|
|||
Foreign
|
|
25
|
|
|
52
|
|
|
27
|
|
|||
Total current
|
|
54
|
|
|
238
|
|
|
276
|
|
|||
Deferred
|
|
|
|
|
|
|
||||||
Federal
|
|
69
|
|
|
59
|
|
|
(557
|
)
|
|||
State
|
|
11
|
|
|
(2
|
)
|
|
25
|
|
|||
Foreign
|
|
(26
|
)
|
|
5
|
|
|
(2
|
)
|
|||
Total deferred
|
|
54
|
|
|
62
|
|
|
(534
|
)
|
|||
Total provision for (benefit from) income taxes
|
|
$
|
108
|
|
|
$
|
300
|
|
|
$
|
(258
|
)
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||
Provision for federal income tax, at statutory rate
|
|
$
|
120
|
|
|
$
|
280
|
|
|
$
|
378
|
|
State income tax provision, net of federal income tax effect
|
|
10
|
|
|
28
|
|
|
26
|
|
|||
Foreign income tax rate differential
|
|
(6
|
)
|
|
14
|
|
|
(36
|
)
|
|||
Manufacturing deduction
|
|
—
|
|
|
—
|
|
|
(23
|
)
|
|||
Depletion
|
|
(5
|
)
|
|
(4
|
)
|
|
(7
|
)
|
|||
Noncontrolling interests
|
|
(8
|
)
|
|
(6
|
)
|
|
(9
|
)
|
|||
Tax Act related adjustment
|
|
—
|
|
|
—
|
|
|
(591
|
)
|
|||
Change in valuation allowance
|
|
(17
|
)
|
|
(9
|
)
|
|
3
|
|
|||
Changes in state apportionment and other state adjustments
|
|
11
|
|
|
(6
|
)
|
|
2
|
|
|||
Other, net
|
|
3
|
|
|
3
|
|
|
(1
|
)
|
|||
Total income tax expense (benefit)
|
|
$
|
108
|
|
|
$
|
300
|
|
|
$
|
(258
|
)
|
|
|
2019
|
|
2018
|
||||
Net operating loss carryforward
|
|
$
|
209
|
|
|
$
|
50
|
|
Credit carryforward
|
|
25
|
|
|
24
|
|
||
Operating lease liabilities
|
|
96
|
|
|
—
|
|
||
Accruals
|
|
65
|
|
|
64
|
|
||
Pension
|
|
83
|
|
|
76
|
|
||
Inventories
|
|
20
|
|
|
13
|
|
||
Other
|
|
26
|
|
|
17
|
|
||
Deferred taxes assets—total
|
|
524
|
|
|
244
|
|
||
Property, plant and equipment
|
|
(1,017
|
)
|
|
(948
|
)
|
||
Intangibles
|
|
(156
|
)
|
|
(148
|
)
|
||
Operating lease right-of-use asset
|
|
(95
|
)
|
|
—
|
|
||
Turnaround costs
|
|
(21
|
)
|
|
(20
|
)
|
||
Consolidated partnerships
|
|
(194
|
)
|
|
(202
|
)
|
||
Equity method investments
|
|
(220
|
)
|
|
(13
|
)
|
||
Other
|
|
(18
|
)
|
|
(14
|
)
|
||
Deferred tax liabilities—total
|
|
(1,721
|
)
|
|
(1,345
|
)
|
||
Valuation allowance
|
|
(30
|
)
|
|
(47
|
)
|
||
Total net deferred tax liabilities
|
|
$
|
(1,227
|
)
|
|
$
|
(1,148
|
)
|
|
|
|
|
|
||||
Balance sheet classifications
|
|
|
|
|
||||
Noncurrent deferred tax asset
|
|
$
|
28
|
|
|
$
|
11
|
|
Noncurrent deferred tax liability
|
|
(1,255
|
)
|
|
(1,159
|
)
|
||
Total net deferred tax liabilities
|
|
$
|
(1,227
|
)
|
|
$
|
(1,148
|
)
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||
Net income attributable to Westlake Chemical Corporation
|
|
$
|
421
|
|
|
$
|
996
|
|
|
$
|
1,304
|
|
Less:
|
|
|
|
|
|
|
||||||
Net income attributable to participating securities
|
|
(2
|
)
|
|
(5
|
)
|
|
(7
|
)
|
|||
Net income attributable to common shareholders
|
|
$
|
419
|
|
|
$
|
991
|
|
|
$
|
1,297
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||
Weighted average common shares—basic
|
|
128,395,184
|
|
|
129,401,823
|
|
|
129,087,043
|
|
|||
Plus incremental shares from:
|
|
|
|
|
|
|
||||||
Assumed exercise of options and vesting of performance stock units
|
|
362,109
|
|
|
583,930
|
|
|
452,970
|
|
|||
Weighted average common shares—diluted
|
|
128,757,293
|
|
|
129,985,753
|
|
|
129,540,013
|
|
|||
|
|
|
|
|
|
|
||||||
Earnings per common share attributable to Westlake Chemical Corporation:
|
|
|
|
|
|
|
||||||
Basic
|
|
$
|
3.26
|
|
|
$
|
7.66
|
|
|
$
|
10.05
|
|
Diluted
|
|
$
|
3.25
|
|
|
$
|
7.62
|
|
|
$
|
10.00
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||
Dividends per common share
|
|
$
|
1.0250
|
|
|
$
|
0.9200
|
|
|
$
|
0.8012
|
|
|
|
Year Ended December 31, 2019
|
||
Operating cash flows from operating leases (1)
|
|
$
|
112
|
|
Right-of-use assets obtained in exchange for operating lease obligations
|
|
119
|
|
(1)
|
Includes cash paid for amounts included in the measurement of operating lease liabilities recorded in the consolidated balance sheets.
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||
Cash paid for:
|
|
|
|
|
|
|
||||||
Interest paid, net of interest capitalized
|
|
$
|
116
|
|
|
$
|
140
|
|
|
$
|
154
|
|
Income taxes paid
|
|
77
|
|
|
376
|
|
|
84
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||
Net external sales
|
|
|
|
|
|
|
||||||
Olefins
|
|
|
|
|
|
|
||||||
Polyethylene
|
|
$
|
1,301
|
|
|
$
|
1,519
|
|
|
$
|
1,518
|
|
Styrene, feedstock and other
|
|
481
|
|
|
500
|
|
|
533
|
|
|||
Total olefins
|
|
1,782
|
|
|
2,019
|
|
|
2,051
|
|
|||
Vinyls
|
|
|
|
|
|
|
||||||
PVC, caustic soda and other
|
|
5,068
|
|
|
5,359
|
|
|
4,769
|
|
|||
Building products
|
|
1,268
|
|
|
1,257
|
|
|
1,221
|
|
|||
Total vinyls
|
|
6,336
|
|
|
6,616
|
|
|
5,990
|
|
|||
|
|
$
|
8,118
|
|
|
$
|
8,635
|
|
|
$
|
8,041
|
|
|
|
|
|
|
|
|
||||||
Intersegment sales
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
324
|
|
|
$
|
500
|
|
|
$
|
393
|
|
Vinyls
|
|
1
|
|
|
2
|
|
|
1
|
|
|||
|
|
$
|
325
|
|
|
$
|
502
|
|
|
$
|
394
|
|
|
|
|
|
|
|
|
||||||
Income (loss) from operations
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
260
|
|
|
$
|
573
|
|
|
$
|
655
|
|
Vinyls
|
|
451
|
|
|
913
|
|
|
639
|
|
|||
Corporate and other
|
|
(55
|
)
|
|
(78
|
)
|
|
(69
|
)
|
|||
|
|
$
|
656
|
|
|
$
|
1,408
|
|
|
$
|
1,225
|
|
|
|
|
|
|
|
|
||||||
Depreciation and amortization
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
142
|
|
|
$
|
138
|
|
|
$
|
145
|
|
Vinyls
|
|
563
|
|
|
491
|
|
|
449
|
|
|||
Corporate and other
|
|
8
|
|
|
12
|
|
|
7
|
|
|||
|
|
$
|
713
|
|
|
$
|
641
|
|
|
$
|
601
|
|
|
|
|
|
|
|
|
||||||
Other income, net
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
5
|
|
|
$
|
4
|
|
|
$
|
3
|
|
Vinyls
|
|
18
|
|
|
35
|
|
|
7
|
|
|||
Corporate and other
|
|
15
|
|
|
13
|
|
|
5
|
|
|||
|
|
$
|
38
|
|
|
$
|
52
|
|
|
$
|
15
|
|
|
|
|
|
|
|
|
||||||
Provision for (benefit from) income taxes
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
60
|
|
|
$
|
128
|
|
|
$
|
63
|
|
Vinyls
|
|
40
|
|
|
212
|
|
|
(302
|
)
|
|||
Corporate and other
|
|
8
|
|
|
(40
|
)
|
|
(19
|
)
|
|||
|
|
$
|
108
|
|
|
$
|
300
|
|
|
$
|
(258
|
)
|
|
|
|
|
|
|
|
||||||
Capital expenditures
|
|
|
|
|
|
|
||||||
Olefins
|
|
$
|
117
|
|
|
$
|
110
|
|
|
$
|
97
|
|
Vinyls
|
|
664
|
|
|
585
|
|
|
459
|
|
|||
Corporate and other
|
|
6
|
|
|
7
|
|
|
21
|
|
|||
|
|
$
|
787
|
|
|
$
|
702
|
|
|
$
|
577
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||
Income from operations for reportable segments
|
|
$
|
656
|
|
|
$
|
1,408
|
|
|
$
|
1,225
|
|
Interest expense
|
|
(124
|
)
|
|
(126
|
)
|
|
(159
|
)
|
|||
Other income, net
|
|
38
|
|
|
52
|
|
|
15
|
|
|||
Income before income taxes
|
|
$
|
570
|
|
|
$
|
1,334
|
|
|
$
|
1,081
|
|
|
|
December 31, 2019
|
|
December 31, 2018
|
||||
Total assets
|
|
|
|
|
||||
Olefins
|
|
$
|
1,991
|
|
|
$
|
2,024
|
|
Vinyls
|
|
10,597
|
|
|
8,879
|
|
||
Corporate and other
|
|
673
|
|
|
699
|
|
||
|
|
$
|
13,261
|
|
|
$
|
11,602
|
|
|
|
Year Ended December 31,
|
||||||||||
|
|
2019
|
|
2018
|
|
2017
|
||||||
Net sales to external customers (1)
|
|
|
|
|
|
|
||||||
United States
|
|
$
|
5,530
|
|
|
$
|
6,114
|
|
|
$
|
5,739
|
|
Foreign
|
|
|
|
|
|
|
||||||
Canada
|
|
573
|
|
|
649
|
|
|
653
|
|
|||
Germany
|
|
478
|
|
|
500
|
|
|
432
|
|
|||
China
|
|
175
|
|
|
155
|
|
|
104
|
|
|||
Italy
|
|
119
|
|
|
105
|
|
|
96
|
|
|||
Taiwan
|
|
84
|
|
|
102
|
|
|
96
|
|
|||
Other
|
|
1,159
|
|
|
1,010
|
|
|
921
|
|
|||
|
|
$
|
8,118
|
|
|
$
|
8,635
|
|
|
$
|
8,041
|
|
|
|
December 31, 2019
|
|
December 31, 2018
|
||||
Long-lived assets
|
|
|
|
|
||||
United States
|
|
$
|
6,012
|
|
|
$
|
5,829
|
|
Foreign
|
|
|
|
|
||||
Germany
|
|
588
|
|
|
528
|
|
||
Other
|
|
312
|
|
|
238
|
|
||
|
|
$
|
6,912
|
|
|
$
|
6,595
|
|
(1)
|
Net sales are attributed to countries based on location of customer.
|
|
|
Three Months Ended
|
||||||||||||||
|
|
March 31,
2019 |
|
June 30,
2019 |
|
September 30,
2019 |
|
December 31,
2019 |
||||||||
Net sales
|
|
$
|
2,025
|
|
|
$
|
2,144
|
|
|
$
|
2,066
|
|
|
$
|
1,883
|
|
Gross profit
|
|
299
|
|
|
340
|
|
|
371
|
|
|
250
|
|
||||
Income from operations
|
|
134
|
|
|
194
|
|
|
226
|
|
|
102
|
|
||||
Net income
|
|
82
|
|
|
129
|
|
|
166
|
|
|
85
|
|
||||
Net income attributable to Westlake Chemical Corporation
|
|
72
|
|
|
119
|
|
|
158
|
|
|
72
|
|
||||
Earnings per common share attributable to Westlake Chemical Corporation:
|
|
|
|
|
|
|
|
|
||||||||
Basic
|
|
$
|
0.56
|
|
|
$
|
0.92
|
|
|
$
|
1.22
|
|
|
$
|
0.56
|
|
Diluted
|
|
$
|
0.55
|
|
|
$
|
0.92
|
|
|
$
|
1.22
|
|
|
$
|
0.56
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
Three Months Ended
|
||||||||||||||
|
|
March 31,
2018 |
|
June 30,
2018 |
|
September 30,
2018 |
|
December 31,
2018 |
||||||||
Net sales
|
|
$
|
2,150
|
|
|
$
|
2,235
|
|
|
$
|
2,255
|
|
|
$
|
1,995
|
|
Gross profit
|
|
542
|
|
|
552
|
|
|
539
|
|
|
354
|
|
||||
Income from operations
|
|
401
|
|
|
404
|
|
|
396
|
|
|
207
|
|
||||
Net income
|
|
297
|
|
|
288
|
|
|
318
|
|
|
131
|
|
||||
Net income attributable to Westlake Chemical Corporation
|
|
287
|
|
|
278
|
|
|
308
|
|
|
123
|
|
||||
Earnings per common share attributable to Westlake Chemical Corporation: (1)
|
|
|
|
|
|
|
|
|
||||||||
Basic
|
|
$
|
2.21
|
|
|
$
|
2.13
|
|
|
$
|
2.36
|
|
|
$
|
0.95
|
|
Diluted
|
|
$
|
2.20
|
|
|
$
|
2.12
|
|
|
$
|
2.35
|
|
|
$
|
0.95
|
|
(1)
|
Basic and diluted earnings per common share ("EPS") for each quarter is computed using the weighted average shares outstanding during that quarter, while EPS for the year is computed using the weighted average shares outstanding for the year. As a result, the sum of the EPS for each of the four quarters may not equal the EPS for the year.
|
(1)
|
These RSUs vest on February 14, 2021.
|
(2)
|
These RSUs vest on February 14, 2025.
|
(a)(1)
|
The financial statements listed in the Index to Consolidated Financial Statements in Item 8 of this Form 10-K are filed as part of this Form 10-K.
|
|
|
(a)(2)
|
All schedules are omitted because the information is not applicable, not required, or has been furnished in the Consolidated Financial Statements or Notes thereto in Item 8 of this Form 10-K.
|
|
|
(a)(3)
|
Exhibits
|
Exhibit No.
|
|
Exhibit Index
|
|
|
|
2.1
|
|
|
|
|
|
3.1
|
|
|
|
|
|
3.2
|
|
|
|
|
|
3.3
|
|
|
|
|
|
3.4
|
|
|
|
|
|
4.1†
|
|
|
|
|
|
4.2
|
|
|
|
|
|
4.3
|
|
|
|
|
|
4.4
|
|
|
|
|
|
4.5
|
|
|
|
|
|
4.6
|
|
|
|
|
|
4.7
|
|
|
|
|
|
4.8
|
|
|
|
|
|
Exhibit No.
|
|
Exhibit Index
|
|
|
|
4.9
|
|
|
|
|
|
4.10
|
|
|
|
|
|
4.11
|
|
|
|
|
|
4.12
|
|
|
|
|
|
4.13
|
|
|
|
|
|
4.14
|
|
|
|
|
|
4.15
|
|
|
|
|
|
4.16
|
|
|
|
|
|
4.17
|
|
|
|
|
|
|
|
Westlake and its subsidiaries are party to other long-term debt instruments not filed herewith under which the total amount of securities authorized does not exceed 10% of the total assets of Westlake and its subsidiaries on a consolidated basis. Pursuant to paragraph 4(iii)(A) of Item 601(b) of Regulation S-K, Westlake agrees to furnish a copy of such instruments to the SEC upon request.
|
|
|
|
10.1
|
|
|
|
|
|
10.2
|
|
|
|
|
|
10.3
|
|
|
|
|
|
Exhibit No.
|
|
Exhibit Index
|
|
|
|
10.4
|
|
|
|
|
|
10.5
|
|
|
|
|
|
10.6
|
|
|
|
|
|
10.7
|
|
|
|
|
|
10.8
|
|
|
|
|
|
10.9
|
|
|
|
|
|
10.10
|
|
|
|
|
|
10.11
|
|
|
|
|
|
10.12
|
|
|
|
|
|
10.13
|
|
|
|
|
|
10.14+
|
|
|
|
|
|
10.15+
|
|
|
|
|
|
10.16+
|
|
|
|
|
|
10.17+
|
|
|
|
|
|
10.18
|
|
|
|
|
|
Exhibit No.
|
|
Exhibit Index
|
|
|
|
10.19
|
|
|
|
|
|
10.20+
|
|
|
|
|
|
10.21+
|
|
|
|
|
|
10.22+
|
|
|
|
|
|
10.23+
|
|
|
|
|
|
21†
|
|
|
|
|
|
23.1†
|
|
|
|
|
|
31.1†
|
|
|
|
|
|
31.2†
|
|
|
|
|
|
32.1††
|
|
|
|
|
|
101.INS†
|
|
XBRL Instance Document-The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document.
|
|
|
|
101.SCH†
|
|
XBRL Taxonomy Extension Schema Document.
|
|
|
|
101.CAL†
|
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
|
101.DEF†
|
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
|
101.LAB†
|
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
|
101.PRE†
|
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
|
|
104
|
|
Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document and contained in Exhibit 101.
|
†
|
Filed herewith.
|
††
|
Furnished herewith.
|
+
|
Management contract, compensatory plan or arrangement.
|
|
|
|
WESTLAKE CHEMICAL CORPORATION
|
|
|
|
|
Date:
|
February 19, 2020
|
|
/S/ ALBERT CHAO
|
|
|
|
Albert Chao, President and Chief Executive Officer
|
Signature
|
|
Title
|
|
Date
|
|
|
|
||
/S/ ALBERT CHAO
|
|
President and Chief Executive Officer
(Principal Executive Officer)
|
|
February 19, 2020
|
Albert Chao
|
|
|||
|
|
|
||
/S/ M. STEVEN BENDER
|
|
Executive Vice President and Chief Financial
Officer (Principal Financial Officer)
|
|
February 19, 2020
|
M. Steven Bender
|
|
|||
|
|
|
||
/S/ GEORGE J. MANGIERI
|
|
Senior Vice President and Chief Accounting
Officer (Principal Accounting Officer)
|
|
February 19, 2020
|
George J. Mangieri
|
|
|||
|
|
|
||
/S/ JAMES CHAO
|
|
Chairman of the Board of Directors
|
|
February 19, 2020
|
James Chao
|
|
|||
|
|
|
||
/S/ ALBERT CHAO
|
|
Director
|
|
February 19, 2020
|
Albert Chao
|
|
|||
|
|
|
|
|
/S/ DAVID T. CHAO
|
|
Director
|
|
February 19, 2020
|
David T. Chao
|
|
|||
|
|
|
||
/S/ JOHN CHAO
|
|
Director
|
|
February 19, 2020
|
John Chao
|
|
|||
|
|
|
|
|
/S/ MICHAEL J. GRAFF
|
|
Director
|
|
February 19, 2020
|
Michael J. Graff
|
|
|||
|
|
|
||
/S/ MARIUS A. HAAS
|
|
Director
|
|
February 19, 2020
|
Marius A. Haas
|
|
|||
|
|
|
|
|
/S/ DOROTHY C. JENKINS
|
|
Director
|
|
February 19, 2020
|
Dorothy C. Jenkins
|
|
|||
|
|
|
||
/S/ MAX L. LUKENS
|
|
Director
|
|
February 19, 2020
|
Max L. Lukens
|
|
|||
|
|
|
||
/S/ MARK A. MCCOLLUM
|
|
Director
|
|
February 19, 2020
|
Mark A. McCollum
|
|
|||
|
|
|
|
|
/S/ R. BRUCE NORTHCUTT
|
|
Director
|
|
February 19, 2020
|
R. Bruce Northcutt
|
|
|||
|
|
|
|
|
/S/ JEFFREY W. SHEETS
|
|
Director
|
|
February 19, 2020
|
Jeffrey W. Sheets
|
|
•
|
the affirmative vote of a majority of directors present at any regular or special meeting of the Board of Directors called for that purpose, provided that any alteration, amendment or repeal of, or adoption of any bylaw inconsistent with specified provisions of the bylaws, including those related to special and annual meetings of stockholders, action of stockholders by written consent, classification of the Board of Directors, nomination of directors, special meetings of directors, removal of directors, committees of the Board of Directors and indemnification of directors and officers, requires the affirmative vote of at least 75% of all directors in office at a meeting called for that purpose; or
|
•
|
the affirmative vote of holders of 75% of the voting power of our outstanding shares of voting stock, voting together as a single class.
|
•
|
make nominations in the election of directors;
|
•
|
propose that a director be removed;
|
•
|
propose any repeal or change in our bylaws; or
|
•
|
propose any other business to be brought before an annual or special meeting of stockholders.
|
•
|
a description of the business or nomination to be brought before the meeting and the reasons for conducting such business at the meeting;
|
•
|
the stockholder’s name and address;
|
•
|
the number of shares of our stock beneficially owned by the stockholder and evidence of such ownership; and
|
•
|
the names and addresses of all persons with whom the stockholder is acting in concert and a description of all arrangements and understandings with those persons, and the number of shares of our stock such persons beneficially own.
|
•
|
in connection with an annual meeting of stockholders, not less than 120 nor more than 180 days prior to the date on which the annual meeting of stockholders was held in the immediately preceding year, but in the event that the date of the annual meeting is more than 30 days before or more than 60 days after the anniversary date of the preceding annual meeting of stockholders, a stockholder notice will be timely if received by us not later than the close of business on the later of (1) the 120th day prior to the annual meeting and (2) the 10th day following the day on which we first publicly announce the date of the annual meeting; or
|
•
|
in connection with the election of a director at a special meeting of stockholders, not less than 40 nor more than 60 days prior to the date of the special meeting, but in the event that less than 55 days’ notice or prior public disclosure of the date of the special meeting of the stockholders is given or made to the stockholders, a stockholder notice will be timely if received by us not later than the close of business on the 10th day following the day on which a notice of the date of the special meeting was mailed to the stockholders or the public disclosure of that date was made.
|
•
|
any breach of the director’s duty of loyalty to our company or our stockholders;
|
•
|
any act or omission not in good faith or which involved intentional misconduct or a knowing violation of law;
|
•
|
unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the Delaware General Corporation Law; and
|
•
|
any transaction from which the director derived an improper personal benefit.
|
•
|
acquisition of control of us by means of a proxy contest or otherwise; or
|
•
|
removal of our incumbent officers and directors.
|
•
|
the principal stockholder affiliates serving as our directors and/or officers;
|
•
|
the principal stockholder affiliates engaging in lines of business that are the same as, or similar to, our lines of business;
|
•
|
the principal stockholder affiliates having an interest in the same areas of corporate opportunity as we have; and
|
•
|
we and the principal stockholder affiliates engaging in material business transactions.
|
•
|
prior to the time the stockholder became an interested stockholder, the Board of Directors approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder;
|
•
|
upon consummation of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, other than statutorily excluded shares; or
|
•
|
on or subsequent to the time the stockholder became an interested stockholder, the business combination is approved by the Board of Directors and authorized at an annual or special meeting of stockholders by the affirmative vote of at least 66 2⁄3% of the outstanding voting stock which is not owned by the interested stockholder.
|
•
|
any person that is the owner of 15% or more of the outstanding voting stock of the corporation, or is an affiliate or associate of the corporation and was the owner of 15% or more of the outstanding voting stock of the corporation at any time within three years immediately prior to the date of determination; and
|
•
|
the affiliates and associates of any such person.
|
•
|
100% of the principal amount of the notes to be redeemed; and
|
•
|
the sum of the present values of the Remaining Scheduled Payments on the notes being redeemed that would be due if the notes matured on the Par Call Date (excluding accrued and unpaid interest to the redemption date), discounted to the redemption date on an annual basis (ACTUAL/ACTUAL (ICMA)) at the applicable Comparable Government Bond Rate plus 30 basis points,
|
•
|
accept or cause a third party to accept for payment all notes or portions of notes properly tendered pursuant to the Change of Control Offer;
|
•
|
deposit or cause a third party to deposit with the paying agent an amount equal to the Change of Control Payment in respect of all notes or portions of notes properly tendered; and
|
•
|
deliver or cause to be delivered to the trustee the notes to be redeemed properly accepted together with an officers’ certificate stating the aggregate principal amount of notes or portions of notes being repurchased and that all conditions precedent to the Change of Control Offer and to the repurchase by us of notes pursuant to the Change of Control Offer have been complied with.
|
•
|
the direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of the assets of Westlake and its Subsidiaries taken as a whole to any “person” or “group” (as those terms are used in Section 13(d)(3) of the Exchange Act) other than to Westlake or one of its Subsidiaries;
|
•
|
the consummation of any transaction (including, without limitation, any merger or consolidation) the result of which is that any “person” or “group” (as those terms are used in Section 13(d)(3) of the Exchange Act, it being agreed that an employee of Westlake or any of its Subsidiaries for whom shares are held under an employee stock ownership, employee retirement, employee savings or similar plan and whose shares are voted in accordance with the instructions of such employee shall not be a member of a “group” (as that term is used in Section 13(d)(3) of the Exchange Act) solely because such employee’s shares are held by a trustee under said plan) becomes the ultimate Beneficial Owner, directly or indirectly, of our Voting Stock representing more than 50% of the voting power of our outstanding Voting Stock;
|
•
|
we consolidate with, or merge with or into, any Person, or any Person consolidates with, or merges with or into, us, in any such event pursuant to a transaction in which any of our outstanding Voting Stock or Voting Stock of such other Person is converted into or exchanged for cash, securities or other property, other than any such transaction where our Voting Stock outstanding immediately prior to such transaction constitutes, or is converted into or exchanged for, Voting Stock representing more than 50% of the voting power of the Voting Stock of the surviving Person or its parent immediately after giving effect to such transaction;
|
•
|
during any period of 24 consecutive calendar months, the majority of the members of our board of directors shall no longer be composed of individuals (a) who were members of our board of directors on the first day of such period or (b) whose election or nomination to our board of directors was approved by individuals referred to in clause (a) above constituting, at the time of such election or nomination, at least a majority of our board of directors or, if directors are nominated by a committee of our board of directors, constituting at the time of such nomination, at least a majority of such committee; or
|
•
|
the adoption of a plan relating to our liquidation or dissolution.
|
•
|
Mortgages on such property or shares of stock or Debt existing on the first date the notes were originally issued;
|
•
|
Mortgages on such property or shares of stock of or Debt of any Person, which Mortgages are existing at the time (1) such Person became a Restricted Subsidiary, (2) such Person is merged into or consolidated with Westlake or any of its Subsidiaries or (3) Westlake or one of its Subsidiaries merges into or consolidates with such Person (in a transaction in which such Person becomes a Restricted Subsidiary), which Mortgage was not incurred in anticipation of such transaction and was outstanding prior to such transaction;
|
•
|
Mortgages in favor of Westlake;
|
•
|
Mortgages in favor of a governmental entity or in favor of the holders of securities issued by any such entity, pursuant to any contract or statute (including Mortgages to secure debt of the pollution control or industrial revenue bond type) or to secure any indebtedness incurred for the purpose of financing all or any part of the purchase price or the cost of construction of the property subject to such Mortgages;
|
•
|
Mortgages in favor of any governmental entity to secure progress, advance or other payments pursuant to any contract or provision of any statute;
|
•
|
Mortgages on such property or shares of stock or Debt existing at the time of acquisition thereof (including acquisition through merger or consolidation);
|
•
|
Mortgages on such property or shares of stock or Debt to secure the payment of all or any part of the purchase price or construction cost thereof or to secure any Debt incurred prior to, at the time of, or within 180 days after, the acquisition of such property or shares or Debt, the completion of any construction or the commencement of full operation, for the purpose of financing all or any part of the purchase price or construction cost thereof;
|
•
|
Mortgages incurred in connection with a Sale and Leaseback Transaction satisfying the provisions described under “—Limitations on Sale and Leaseback Transactions” below; and
|
•
|
any extension, renewal or replacement (or successive extensions, renewals or replacements), as a whole or in part, of any Mortgage referred to in the foregoing bullet points; provided that such extension, renewal or replacement Mortgage shall be limited to all or a part of the same such property or shares of stock or Debt that secured the Mortgage extended, renewed or replaced (plus improvements on such property).
|
•
|
such Sale and Leaseback Transaction is with a governmental entity that provides financial or tax benefits;
|
•
|
we or such Restricted Subsidiary could create Secured Debt pursuant to the provisions described under “—Restrictions on Secured Debt” on the Principal Property to be leased in an amount equal to the Attributable Debt with respect to such Sale and Leaseback Transaction without equally and ratably securing notes issued under the indenture; or
|
•
|
the net proceeds of the sale or transfer of the Principal Property leased pursuant to such Sale and Leaseback Transaction is at least equal to the fair market value of such Principal Property and (b) within 180 days after such sale or transfer shall have been made by us or by a Restricted Subsidiary, we apply an amount not less than the greater of (1) the net proceeds of the sale of the Principal Property leased pursuant to such arrangement or (2) the fair market value of the Principal Property so leased at the time of entering into such arrangement (as evidenced by an officers’ certificate delivered to the trustee) to the retirement of Funded Debt (as defined below) of Westlake; provided that the amount to be applied to the retirement of Funded Debt of Westlake shall be reduced by (x) the principal amount of notes issued under the indenture delivered within 180 days after such sale to the trustee for retirement and cancellation, and (y) the principal amount of Funded Debt other than notes issued under the indenture, voluntarily retired by us within 180 days after such sale. No retirement referred to in this bullet point may be effected by payment at maturity or pursuant to any mandatory sinking fund payment or mandatory prepayment provision.
|
•
|
the resulting, surviving or transferee Person is either Westlake or is a corporation organized under the laws of the United States, any state thereof, or the District of Columbia, and, if not Westlake, the resulting entity assumes by a supplemental indenture the due and punctual payments on the notes and the performance of our covenants and obligations under the indenture; and
|
•
|
immediately after giving effect to the transaction, no default or event of default under the indenture has occurred and is continuing or would result from the transaction.
|
•
|
our failure to pay interest on the notes for 30 days after becoming due;
|
•
|
our failure to pay principal of or any premium on the notes when due;
|
•
|
our failure to comply with any covenant or agreement of the notes or the indenture (other than an agreement or covenant that has been included in the indenture solely for the benefit of another series of notes) for 60 days after written notice by the trustee or by the holders of at least 25% in principal amount of the outstanding notes issued under the indenture that are affected by that failure; and
|
•
|
specified events involving bankruptcy, insolvency or reorganization of Westlake.
|
•
|
the holder gives the trustee written notice of a continuing event of default with respect to the notes;
|
•
|
the holders of at least 25% in principal amount of the outstanding notes make a written request to the trustee to pursue the remedy;
|
•
|
the holders offer to the trustee indemnity satisfactory to the trustee against any loss, liability or expense;
|
•
|
the trustee does not comply with the request within 60 days after receipt of the request and offer of indemnity; and
|
•
|
during that 60-day period, the holders of a majority in principal amount of the notes do not give the trustee a direction inconsistent with the request.
|
•
|
conducting any proceeding for any remedy available to the trustee; or
|
•
|
exercising any trust or power conferred on the trustee relating to or arising as a result of an event of default.
|
•
|
reduce the amount of notes whose holders must consent to an amendment, supplement or waiver;
|
•
|
reduce the rate of or change the time for payment of interest on the notes;
|
•
|
reduce the principal of the notes or change their stated maturity;
|
•
|
reduce any premium payable on the redemption of the notes or change the time at which the notes may or must be redeemed;
|
•
|
change any obligation to pay additional amounts on the notes;
|
•
|
make payments on the notes payable in currency other than as originally stated in the notes;
|
•
|
impair the holder’s right to institute suit for the enforcement of any payment on or with respect to the notes;
|
•
|
make any change in the percentage of principal amount of notes necessary to waive compliance with certain provisions of the indenture or to make any change in the provision related to modification; and
|
•
|
waive a continuing default or event of default regarding any payment on the notes.
|
•
|
to cure any ambiguity, omission, defect or inconsistency;
|
•
|
to conform the provisions of the indenture (as amended or supplemented) or the notes to the “Description of the Senior Notes” section of the applicable prospectus supplement;
|
•
|
to provide for the assumption of our obligations under the indenture by a successor upon any merger, consolidation or asset transfer permitted under the indenture;
|
•
|
to provide for uncertificated notes in addition to or in place of certificated notes or to provide for bearer notes;
|
•
|
to provide any security for, or to add any guarantees of or obligors on, any series of notes;
|
•
|
to comply with any requirement to effect or maintain the qualification of the indenture under the Trust Indenture Act of 1939;
|
•
|
to add covenants that would benefit the holders of any notes or to surrender any rights we have under the indenture;
|
•
|
to add events of default with respect to any series of notes;
|
•
|
to make any change that does not adversely affect any outstanding notes of any series issued under the indenture in any material respect; and
|
•
|
to establish the form or terms of any notes and to accept the appointment of a successor trustee, each as permitted under the indenture.
|
•
|
we will be discharged from our obligations with respect to the notes (“legal defeasance”); or
|
•
|
we will no longer have any obligation to comply with specified restrictive covenants with respect to the notes, the covenant described under “—Certain Covenants—Limitations on Consolidations, Mergers and Sales of Assets” above and other specified covenants under the indenture, and the related events of default will no longer apply (“covenant defeasance”).
|
•
|
either
|
o
|
all outstanding notes have been delivered to the trustee for cancellation; or
|
o
|
all outstanding notes not delivered to the trustee for cancellation either:
|
§
|
have become due and payable
|
§
|
will become due and payable at their stated maturity within one year, or
|
§
|
are to be called for redemption within one year; and
|
§
|
we have deposited with the trustee any combination of money or government securities in trust sufficient to pay the entire indebtedness on the notes when due; and
|
§
|
we have paid all other sums payable by us with respect to the notes.
|
•
|
transfers of securities and cash within Euroclear;
|
•
|
withdrawal of securities and cash from Euroclear; and
|
•
|
receipt of payments with respect to securities in Euroclear.
|
Name of Subsidiary
|
|
State or Other Jurisdiction
of Incorporation or
Organization
|
|
Names Doing Business
|
|
|
|
|
|
Axiall Canada, Inc.
|
|
Canada
|
|
Axiall Canada, Inc.
|
|
|
|
|
|
Axiall Corporation
|
|
Delaware
|
|
Axiall Corporation
|
|
|
|
|
|
Axiall Holdco, Inc.
|
|
Delaware
|
|
Axiall Holdco, Inc.
|
|
|
|
|
|
Axiall Limited Partnership
|
|
Ontario
|
|
Axiall Limited Partnership
|
|
|
|
|
|
Axiall Noteco, Inc.
|
|
Delaware
|
|
Axiall Noteco, Inc.
|
|
|
|
|
|
Axiall Taiwan Ltd.
|
|
Taiwan
|
|
Axiall Taiwan Ltd.
|
|
|
|
|
|
Axiall, LLC
|
|
Delaware
|
|
Axiall, LLC
|
|
|
|
|
|
Eagle Natrium LLC
|
|
Delaware
|
|
Eagle Natrium LLC
|
|
|
|
|
|
Eagle Spinco Inc.
|
|
Delaware
|
|
Eagle Spinco Inc.
|
|
|
|
|
|
Eagle US 2 LLC
|
|
Delaware
|
|
Eagle US 2 LLC
|
|
|
|
|
|
Lagoon LLC
|
|
Delaware
|
|
Lagoon LLC
|
|
|
|
|
|
North American Pipe Corporation
|
|
Delaware
|
|
North American Pipe Corporation
and NAPCO
|
|
|
|
|
|
North American Specialty Products LLC
|
|
Delaware
|
|
North American Specialty Products LLC
|
|
|
|
|
|
Plastic Trends, Inc.
|
|
Michigan
|
|
Plastic Trends, Inc.
|
|
|
|
|
|
Rome Acquisition Holding Corp.
|
|
Nova Scotia
|
|
Rome Acquisition Holding Corp.
|
|
|
|
|
|
Rome Delaware Corp.
|
|
Delaware
|
|
Rome Delaware Corp.
|
|
|
|
|
|
Royal Building Products (USA) Inc.
|
|
Delaware
|
|
Royal Building Products (USA) Inc.
|
|
|
|
|
|
Royal Group, Inc.
|
|
Canada
|
|
Royal Group, Inc.
|
|
|
|
|
|
Taiwan Chlorine Industries Ltd.
|
|
Taiwan
|
|
Taiwan Chlorine Industries Ltd.
|
|
|
|
|
|
Vinnolit Benelux-France B.V.B.A.
|
|
Dendermonde, Belgium
|
|
Vinnolit Benelux-France B.V.B.A.
|
|
|
|
|
|
Vinnolit GmbH & Co. KG
|
|
Ismaning, Germany
|
|
Vinnolit GmbH & Co. KG
|
|
|
|
|
|
Vinnolit Holdings GmbH
|
|
Ismaning, Germany
|
|
Vinnolit Holdings GmbH
|
|
|
|
|
|
Vinnolit Italia S.r.L.
|
|
Milan, Italy
|
|
Vinnolit Italia S.r.L.
|
|
|
|
|
|
Vinnolit Limited
|
|
United Kingdom
|
|
Vinnolit Limited
|
|
|
|
|
|
Vinnolit Monomer Geschäftsführungs GmbH
|
|
Ismaning, Germany
|
|
Vinnolit Monomer Geschäftsführungs GmbH
|
|
|
|
|
|
Vinnolit Schkopau GmbH
|
|
Ismaning, Germany
|
|
Vinnolit Schkopau GmbH
|
|
|
|
|
|
Vinnolit Treuhand GmbH
|
|
Ismaning, Germany
|
|
Vinnolit Treuhand GmbH
|
|
|
|
|
|
Westlake Chemical Finance Corporation
|
|
Delaware
|
|
Westlake Chemical Finance Corporation
|
|
|
|
|
|
Westlake Chemical Investments, Inc.
|
|
Delaware
|
|
Westlake Chemical Investments, Inc.
|
|
|
|
|
|
Westlake Chemical OpCo LP
|
|
Delaware
|
|
Westlake Chemical OpCo LP
|
|
|
|
|
|
Westlake Chemical Partners GP LLC
|
|
Delaware
|
|
Westlake Chemical Partners GP LLC
|
|
|
|
|
|
Westlake Chemical Partners LP
|
|
Delaware
|
|
Westlake Chemical Partners LP
|
|
|
|
|
|
Westlake Compounds LLC
|
|
Delaware
|
|
Westlake Compounds LLC
|
|
|
|
|
|
Westlake Development Corporation
|
|
Delaware
|
|
Westlake Development Corporation
|
|
|
|
|
|
Westlake International Holdings Cooperatief U.A.
|
|
The Netherlands
|
|
Westlake International Holdings Cooperatief U.A.
|
|
|
|
|
|
Westlake International Holdings II C.V.
|
|
The Netherlands
|
|
Westlake International Holdings II C.V.
|
|
|
|
|
|
Westlake International I B.V.
|
|
The Netherlands
|
|
Westlake International I B.V.
|
|
|
|
|
|
Westlake Longview Corporation
|
|
Delaware
|
|
Westlake Longview Corporation
|
|
|
|
|
|
Westlake Management Services, Inc.
|
|
Delaware
|
|
Westlake Management Services, Inc.
|
|
|
|
|
|
Westlake Olefins LLC
|
|
Delaware
|
|
Westlake Olefins LLC
|
|
|
|
|
|
Westlake Petrochemicals LLC
|
|
Delaware
|
|
Westlake Petrochemicals LLC,
Westlake Petrochemicals LP and WPE
|
|
|
|
|
|
Westlake Polymers LLC
|
|
Delaware
|
|
Westlake Polymers LLC,
Westlake Polymers LP and WPE
|
|
|
|
|
|
Westlake Styrene LLC
|
|
Delaware
|
|
Westlake Styrene LLC
|
|
|
|
|
|
Westlake Switzerland GmbH
|
|
Switzerland
|
|
Westlake Switzerland GmbH
|
|
|
|
|
|
Westlake Vinyls Company LP
|
|
Delaware
|
|
Westlake Vinyls Company LP
|
|
|
|
|
|
Westlake Vinyl Corporation
|
|
Delaware
|
|
Westlake Vinyl Corporation
|
|
|
|
|
|
Westlake Vinyls, Inc.
|
|
Delaware
|
|
Westlake Vinyls, Inc.
|
|
|
|
|
|
WPT LLC
|
|
Delaware
|
|
WPT LLC and WPT LP
|
|
|
|
|
|
*
|
Westlake has elected to omit the names of certain subsidiaries. None of the omitted subsidiaries, considered either alone or together with the other omitted subsidiaries of its immediate parent, constitutes a “Significant Subsidiary” as set forth in Section 601(b)(21) of Regulation S-K.
|
1.
|
I have reviewed this annual report on Form 10-K of Westlake Chemical Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date:
|
February 19, 2020
|
|
/s/ ALBERT CHAO
|
|
|
|
Albert Chao
President and Chief Executive Officer
(Principal Executive Officer) |
1.
|
I have reviewed this annual report on Form 10-K of Westlake Chemical Corporation;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a)
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b)
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c)
|
evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d)
|
disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
|
5.
|
The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
|
a)
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
|
b)
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
|
Date:
|
February 19, 2020
|
|
/s/ M. STEVEN BENDER
|
|
|
|
M. Steven Bender
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)
|
(1)
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
February 19, 2020
|
|
/s/ ALBERT CHAO
|
|
|
|
Albert Chao
President and Chief Executive Officer
(Principal Executive Officer) |
|
|
|
|
Date:
|
February 19, 2020
|
|
/s/ M. STEVEN BENDER
|
|
|
|
M. Steven Bender
Executive Vice President and Chief Financial Officer
(Principal Financial Officer)
|